






Development of a genetically encoded site-specific fluorescent sensor of human cardiac 
voltage-gated sodium channel inactivation 

















Submitted in partial fulfillment  
of the requirements for the degree  
of Doctor of Philosophy  
under the Executive Committee  























































Mia A. Shandell 




Development of a genetically encoded site-specific fluorescent sensor of human cardiac voltage-gated 
sodium channel inactivation 
Mia A. Shandell 
 
Genetic mutations perturbing inactivation of human cardiac voltage-gated sodium channels 
(VGSCs), specifically Nav1.5, can cause long QT syndrome type 3 (LQT3). LQT3 is a cardiac 
disorder in which patients experience syncope and ventricular tachyarrhythmia, and are thus 
predisposed to sudden cardiac death. Deeper understanding of the structural dynamics of VGSC 
inactivation is needed to inform treatment of and drug design for potentially life-threatening 
arrhythmias. A well supported hypothesis is that the VGSC inactivated state is stabilized by 
hydrophobic interactions between the inactivation gate and an unknown binding site potentially 
involving the underside of the channel pore, C-terminus (C-T), and auxiliary proteins [1]. Despite 
advances in biophysical and structural characterization of VGSCs, the specific molecular 
components and timing of their interactions within the inactivation complex remain unclear. 
Fluorescence imaging approaches that connect conformational change with channel function in 
mammalian cells could provide much needed mechanistic insight on the structural dynamics of the 
VGSC inactivation complex. 
This thesis describes the development of a site-specific fluorescent unnatural amino acid 
(UAA) labeling and spectral imaging methodology to probe the cardiac VGSC, Nav1.5, 
inactivation complex in live mammalian cells. First, UAA mutagenesis experiments were 
performed to validate orthogonal synthetase-tRNA (aaRS-tRNA) technology for fluorescent 
labeling of intracellular and membrane proteins in mammalian cells. Next, towards investigating 
conformational dynamics and intramolecular interactions related to inactivation, the Nav1.5
 
 
inactivation gate was labeled with a single environmentally sensitive fluorescent UAA L-anap. 
While the function of L-anap labeled channels was altered, their function remained within 
pathophysiological range. Then, imaging of L-anap labeled Nav1.5 in mammalian cells afforded 
characterization of unique L-anap spectra at different sites in the inactivation gate. Finally, using 
potassium-depolarization (K-depolarization) as rough means of voltage control, L-anap spectral 
shifts demonstrated conformational changes between the closed and open-inactivated states, which 
depended on the presence of the distal C-T (DCT).  
Site-specific L-anap labeling of the inactivation gate combined with spectral imaging and 
K-depolarization affords a general imaging assay to directly monitor conformational 
rearrangements of the Nav1.5 inactivation gate in channels expressed in live mammalian cells. 
While interactions with the DCT are specifically probed, this general assay provides an 
opportunity to bring necessary unification of ideas about VGSC inactivation, as well as insight on 
outstanding questions of VGSC regulation. 
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Chapter 1 introduces advances and challenges in biophysical characterization of ion channels from 
a structure-function perspective. First, classical strategies for studying ion channel biophysics are 
discussed. Second, live-cell imaging techniques for studying ion channels are summarized, 
focusing on fluorescent labeling of ion channels and how these approaches can deepen our 
understanding of ion channel physiology.  
1.1 Basic background on ion channels 
Electrical signals generated by ionic currents across cell membranes underlie cellular excitability 
and are central to all rapid biological processes, including cardiac and neuronal action potentials, 
and excitation-contraction coupling [2]. Ion channels are large protein complexes that regulate the 
flow of ions across amphiphilic phospholipid membranes. Since the development of the patch-
clamp technique by Neher and Sakmann, it is possible to directly measure electrical function of 
individual ion channels [3]. We have learned that these pore-forming membrane proteins modulate 
electrical signals by gating ion flow across the cell membrane and membranes of many intracellular 
organelles. At rest, the gate is closed, blocking ion transport through the channel. Upon 
stimulation, the gate opens, allowing ion conduction. Gating can be stimulated by voltage, 
extracellular ligands, intracellular second messengers, temperature, pressure, or light.  
 Given the wide range of gating possibilities, it is no wonder that ion channels form a major 
part of the sensing infrastructure of biological organisms. Furthermore, the sensitivity and 
specificity of this sensing is encoded into the ion channel molecular structure. Amazing complexity 
is built upon a scaffold of multiple domains, each with extracellular and intracellular loops, pore, 
selectivity filter, and sensing domains for particular gating stimuli. Ion channels are responsible 
for the electrical activity underlying the heartbeat, neuronal activity, and muscular contraction, 
amongst other life-sustaining processes. Consequently, ion channel mutations underlie numerous 
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excitability-related disorders, many of which are debilitating and potentially deadly. Among these 
disorders, named channelopathies, are cystic fibrosis, congenital insensitivity to pain, long and 
short QT syndromes, epilepsy, and retinitis pigmentosa [4], [5]. Ion channels also play a role in 
non-excitable contexts, such as development and cancer metastasis [6]. As a result, ion channels 
are much sought-after drug targets for a variety of diseases. 
 Long QT syndrome (LQTS) is an inherited channelopathy that can cause sudden death 
from cardiac arrhythmias. LQTS is characterized by delayed repolarization of cardiac ventricular 
myocytes following a heartbeat, resulting from prolonged ventricular action potential (AP) 
duration. LQTS involves more than 700 mutations in 12 genes, with the most prevalent mutations 
occurring in potassium channels of the Kv family (LQT1, LQT2). The second most prevalent 
mutations occur in the cardiac voltage-gated sodium channel (VGSC) Nav1.5 causing LQT3, 
which accounts for 2-8% of LQTS patients [7]. LQT3 is characterized by different types of 
arrhythmias, which result from  prolonged AP duration due to slow or incomplete inactivation of 
Nav1.5 channels [8]. Impaired channels lead to prolonged entry of sodium ions into cells, leading 
to delayed repolarization. Since genetic mutations in Nav1.5 often result in LQT3, it is critical to 
learn how these mutations pathologically alter the conformational changes necessary for healthy 
ion conduction in the heart.  
The cardiac AP relies on coordinated depolarization and repolarization of cardiac cells 
mediated by voltage-gated ion channels (VGIC) [8]. Nav1.5 channels generate the upstroke of 
atrial and ventricular cardiac APs. Upon initial depolarization, channels open and conduct inward 
current (INa) of up to 10
7 sodium ions per second [8]. At the hyperpolarized resting membrane 
potential (RMP) of a cardiomyocyte (~-80 mV), sodium channels rest in a closed state, available 
for opening in response to an AP [8]. When an AP depolarizes the membrane, channels open for 
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~1-2 ms and influx sodium, further depolarizing the membrane [8]. At the AP peak, sodium 
channels change conformation to a non-conducting inactivated state, and they cannot open until 
re-assuming the closed state [8]. Since the first electrical recording of sodium current in 1952, 
much progress has been made in understanding the complex mechanisms by which Nav1.5 and 
VGSCs in general carry out their diverse functions [9]. Exact visualization and assignment of 
functional states of the human VGSC structure, however, remain elusive.  
1.2 Fundamental properties of sodium currents  
In 1952, Alan Hodgkin and his student, Andrew Huxley, first reported their observations of ionic 
currents measured by voltage clamp of the squid giant axon [9]. The Hodgkin–Huxley model 
describes initiation of the AP by inward INa, then fast inactivation of INa with simultaneous 
activation of outward IK, which reestablishes charge balance across the membrane [10]. Voltage-
clamp recordings of squid giant axon in sodium-free solutions containing organic cations show 
that, upon depolarization, the axon membrane is transiently permeable to these cations and 
tetrodotoxin (TTX) was later shown to abolish this effect [11]–[15]. Despite the growing evidence 
for the existence of VGSCs, physiologists still had not proved biochemically that TTX receptors 
were also sodium-conducting [16]. In the 1980s, the Catterall group purified the VGSC from 
Rattus norvegicus brain and reconstituted the proteins in planar lipid bilayers [17]. Subsequent 
voltage-clamp recording demonstrated sodium flux, confirming that the purified protein was in 
fact a functional VGSC [16] The first complementary DNA (cDNA) for a VGSC α subunit from 
Electrophorus electricus was obtained by Shosaku Numa’s group in 1984 [18]. When the cloned 
cDNAs were expressed heterologously in Xenopus laevis oocytes, TTX-sensitive sodium current 
was observed [19]. Since these significant discoveries, much structural and functional information 
gained has confirmed many of the initial predictions made by Hodgkin and Huxley [16].  
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1.3 Molecular basis of voltage-gated sodium channel function 
VGSCs are large macromolecular transmembrane complexes consisting of a pore-forming α 
subunit of 260 kDa, Nav1.1-Nav1.9 (SCN1A,2A,3A,4A,5A,8A,9A,10A,11A), and any number of 
up to five β subunits of 30-40 kDa, β1/β1b-β4 (SCN1B-SCN4B) [20]. TTX is a selective inhibitor 
of VGSCs and interacts with amino acids in a short α helical segment of the pore loop between S5 
and S6. Channels can be classified by their response to this interaction as TTX-sensitive – Nav1.1-
1.4, Nav1.6, and Nav1.7, blocked by nM concentrations – and TTX-resistant – Nav1.5, 1.8, and 1.9, 
blocked by μM concentrations [1]. 
Nav1.5, encoded by the gene SCN5A, is a sub-type of the VGSC family that is primarily 
expressed in the heart [21]. SCN5A was first cloned and expressed in X. laevis oocytes in 1992 
[22]. Tetrameric VGSC α subunits are sufficient to form a conducting pore and contain 
intracellular N- and C-termini. Nav1.5α subunits consist of four semi-homologous domains (I-IV), 
each comprised of six transmembrane segments (S1-S6) (Figure 1.1) [18]. The positively charged 
transmembrane S4 segments carry the majority of the gating charge of the voltage sensor, and re-
entrant extracellular loops linking S5 and S6 of each domain form the conducting pore [23]. Ion 
selectivity is determined by the selectivity filter, which is composed of a molecular sieve formed 
by partial membrane penetrating loops S5-S6 of each domain [24].  
Voltage-dependent activation occurs as membrane depolarization drives outward 
movement of positive gating charges in the voltage sensors (S4 segments) via a sliding-helix 
mechanism. The outward movement triggers a conformational change in the pore module, thus 
opening its intracellular activation gate [21]. Four highly conserved glutamate residues in the 
selectivity filter conduct hydrated sodium ions in single file rapidly and selectively [21], [25]. Ion 
conductance is terminated by voltage-dependent inactivation, which causes asymmetric pore 
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collapse [21]. The ~50 amino acid linker between domains III and IV is the inactivation gate, and 
much evidence suggests the III-IV linker interacts with regions of the intracellular C-terminus (C-
T), underside of the pore and possibly auxiliary proteins to form the inactivation complex [1].  
 
Figure 1.1: Voltage-gated sodium channel structure. The α subunit is composed of four semi-
homologous domains (I-IV) each containing six transmembrane segments (S1-S6). S4 of each 
domain contains positively charged amino acids forming the voltage sensing region of the channel. 
Bolded loops between S5 and S6 of each domain are negatively charged and form the pore. The 
linker between domains III and IV is the inactivation gate. β subunits contain a single 
transmembrane domain, intracellular C-T and extracellular Ig binding domain on the N-terminus. 
 VGSC β subunits are Type I intrinsic membrane proteins with a short intracellular C-T and 
an extracellular V-type immunoglobulin (Ig) binding domain on the N-terminus. β subunits 
regulate cell adhesion and α subunit trafficking and gating [16]. The non-covalently bound β1 and 
β3 were first identified in 1985 and 2000, respectively [26]–[28]. β2 and β4 are covalently 
associated with α via one or more disulfide bonds [26], [29]. Generally, in heterologous 
mammalian systems, β subunits increase INa density, shift the voltage-dependence of steady-state 
activation (SSA) and inactivation (SSI), and increase the rates of activation and inactivation [16]. 
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1.4 Visualizing voltage-gated sodium channel structure 
Most of what is known about the structural basis of ion channel function is gleaned from x-ray 
crystallography, cryo-electron microscopy (cryo-EM), and nuclear magnetic resonance (NMR) of 
purified ion channel proteins or protein fragments. An advantage of these techniques is atomic or 
near atomic resolution of the channel of interest, allowing comparison of ion channels with 
different gating dependence (voltage, temperature, etc.) and ion selectivity. The first x-ray crystal 
structure of a prokaryotic VGSC was published in 2011 [25]. This VGSC was from Arcobacter 
butzleri (NavAb), and was captured in a hybrid closed-pore conformation with four active voltage 
sensors [25]. The VGSC structure from Magnetococcus marinus (NavMs) depicts a potential open 
conformation and structures of NavAb reveal two potential inactivated states [30], [31].  
In prokaryotic [25] and eukaryotic [24], [32] VGSCs, the domain-swapped architecture of 
the α subunit is observed. The voltage sensing helix (S4) of one domain interacts with the pore 
module of the neighboring domain. The four domains interlock diagonally forming the central 
pore. It looks like diagonal, interlocked dumbbells; when twisted one way, the channel opens in 
an iris-like fashion. When twisted the opposite way, the channel closes in an iris-like fashion [1]. 
This configuration suggests a concerted movement during activation, because domain movement 
is tethered. Bacterial channels and many relevant domains of mammalian VGSCs lack sufficient 
homology for proper comparison. For example, the bacterial channels are homotetrameric, in 
contrast to eukaryotic channels, which exist as a single subunit containing four covalently linked 
homodomains [33]. In addition, prokaryotic VGSCs do not contain the fast inactivation gate found 
in eukaryotic VGSCs, making prediction of the structure of the inactivation complex difficult [30]. 
 Structures of truncated regions of eukaryotic VGSCs, such as the III-IV linker, in complex 
with accessory proteins have been reported; however, their functional significance is unknown 
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[33], [34]. In particular, the eukaryotic III-IV linker bound to calcium/Calmodulin (CaM) has been 
crystallized [33]. Also, the crystal structure of eukaryotic Nav1.5 C-T domain in complex with 
fibroblast growth factor homologous factor (FHF) and apo-CaM has been resolved [34]. Helix 6 
(H6) in this structure of the C-T differs significantly from a solution NMR structure of apo-CaM-
bound C-T as well as a previous structural model of the C-T [35], [36]. Considered together, these 
results raise questions of how the III-IV linker, C-T, calcium, and CaM may interact in the 
inactivation complex of full-length eukaryotic channels (section Considering calcium). 
 Not until the first structure of a putative eukaryotic VGSC was determined were we able 
to visualize the complete eukaryotic III-IV linker [24]. Recently, Nieng Yan’s group published the 
first cryo-EM structure of a putative eukaryotic VGSC Periplaneta americana NavPaS [24]. The 
assignment of the structure as a sodium channel is putative because it could not be patched in 
heterologous systems, and its function could not be verified [24]. Thus, it is unknown whether 
NavPaS undergoes fast inactivation. In this structure, the III-IV linker comprises an α helix 
followed by a long unwound segment [24]. The complete III-IV linker is resolved; instead of the 
IFM motif found in human channels, these amino acids are ATD [24]. Due to the lack of functional 
information for NavPaS, we cannot conclude definitively upon the significance of the observed III-
IV linker-C-T interaction to inactivation. Another eukaryotic structure of the functionally 
characterized Electrophorus electricus Nav1.4, in complex with β1, was published by Nieng Yan 
a few months after NavPaS was published [32]. The Nav1.4 structure shows the III-IV linker bound 
to the underside of the pore, but the C-T was not resolved [32]. A limitation of structural techniques 
is that there is no membrane potential in a protein crystal. Therefore, it is difficult to assign the 
resolved structure to voltage-dependent functional VGIC states. Therefore, additional approaches, 
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such as mutagenesis, biochemistry, and imaging, can help elucidate the structural and functional 
details of Nav1.5 inactivation, as described in the next section. 
1.5 Voltage-gated sodium channel inactivation 
Evidence that the III-IV Linker is the fast inactivation gate 
VGSCs undergo two distinct mechanisms of inactivation. Fast inactivation occurs in 0.5-10 ms 
and voltage-dependent slow inactivation occurs in tens to hundreds of milliseconds [10], [37]. The 
role of fast inactivation in nerves and muscle cells is to stop sodium current with a half-life of 1-3 
ms [1], [23]. VGSC fast inactivation is thought to occur by a hinged-lid mechanism requiring the 
presence of a conserved hydrophobic motif, typically IFM, in the III-IV linker [38]. This 
hydrophobic motif, known as the inactivation particle, is thought to stabilize a channel 
conformation in which the III-IV linker occludes the intracellular mouth of the pore and halts ion 
conduction [38]–[42]. The IFM motif assumes a stable fast inactivated state by docking onto the 
underside of the pore via hydrophobic interactions, mainly with sites on the DIII:S4-S5 linker, 
DIV:S4-S5 linker, and DIV:S6 [42]–[50]. While the III-IV linker hinged-lid model of fast 
inactivation remains a well-supported hypothesis of the mechanism of fast inactivation, eukaryotic 
structures published recently suggest a potential allosteric mechanism, associating more subtle 
motion of the III-IV linker with fast inactivation [24], [32].  
 The first evidence that the III-IV linker is the inactivation gate was that application of an 
antibody against the III-IV linker slowed inactivation, the effect of which was blocked by 
competition with the corresponding peptide antigen [51]. The same III-IV linker antibody inhibited 
inactivation of single channels [52]. When all 15 charged residues of the ~50 amino acid III-IV 
linker were mutated, all mutants that expressed had inactivation kinetics similar to wild-type [53]. 
Deletion mutants showed that the first 10 amino acids of the III-IV linker were necessary for fast 
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inactivation, while deletion of the last 10 amino acids had no effect [53]. Mutation of IFM to QQQ 
completely removed fast inactivation, I to Q slowed inactivation and inactivation could not 
complete, M to Q slowed inactivation, and F to Q removed inactivation almost completely. These 
data suggest that IFM, and F in particular, forms a hydrophobic latch that stabilizes the inactivated 
state; the T just downstream of IFM was later found to aid in stabilization of the inactivated state 
[40], [43]. Substituted cysteine accessibility to methanethiosulfonate (MTS) modification showed 
F of the IFM motif to move from an exposed modifiable position to a buried position upon 
inactivation, and, in single channels, this modification slowed inactivation and destabilized the 
inactivated state [41]. These elegant original experiments implicate the III-IV linker as the 
inactivation gate, but since then, much research has shown that the III-IV linker acts in complex 
with other channel regions and auxiliary proteins to enact fast inactivation [54].   
Role of the C-T and interaction with the III-IV linker in fast inactivation 
There is evidence that the C-T is also important for regulating channel inactivation, demonstrated 
by functional characterization of many LQT3-associated mutations in the C-T [55]–[59]. Ion 
channel chimeras, fusion of the C-T from one sub-type with the remainder of the α subunit of 
another, have elucidated the functional effects of the C-T on inactivation. For example, exchange 
of the Nav1.5 C-T with brain Nav1.2 C-T increased the rate of inactivation and shifted SSI towards 
more depolarized potentials [60]. The Nav1.5 C-T fused to Nav1.2 slowed inactivation and shifted 
SSI towards hyperpolarized potentials, suggesting a role for the C-T in regulation of channel 
availability and inactivation kinetics [60]. The inactivated state is stabilized by an interaction 
between the III-IV linker and C-T, forming an inactivation complex, and this requires the presence 
of the most distal helix of the C-T structured region, Helix 6 (H6) [35], [45], [61]–[63].  
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One limitation to the numerous studies supporting the significance of a direct III-IV linker 
C-T interaction is the measurement of interactions between purified III-IV linker and C-T peptides, 
not in full-length channels. As patch-clamp electrophysiology has enabled exhaustive functional 
characterization of full-length channels in the native cell environment, approaches to observing 
the structural dynamics and intramolecular interactions of full-length channels in cells are required 
to place cell-free results in physiological context.  
Considering calcium 
There is controversy as to whether sodium channels are regulated by calcium and if they are, how. 
Calcium and the calcium-binding protein calmodulin (CaM) have been shown to cause a 
hyperpolarizing shift in SSI of Nav1.4, but not Nav1.5 [64]. In contrast, increased intracellular 
calcium was shown to shift SSI of Nav1.5 in the depolarizing direction [65], and other studies 
reported no significant shifts in the SSI of Nav1.4 [66], [67]. It has been demonstrated that 
increased intracellular calcium modulates gain-of-function properties of Nav1.5 LQT3 mutants, 
including ΔKPQ in the III-IV linker and 1795insD, Q1909R, and E1784K in the C-T [68]. CaM 
has been shown biochemically to target the same region on the Nav1.5 C-T H6 – the IQ motif, a 
canonical CaM binding sequence – as the III-IV linker, and thus may compete with the III-IV 
linker for similar binding sites during inactivation [36], [69]–[71]. However, the purified C-T EF-
hand domain has also been shown to bind the H6 IQ motif [72], [73]. Structural characterization 
of the regions putatively involved in calcium/CaM regulation has aided visualization of how 
calcium regulation may occur, including participation of the III-IV linker [33], [74], C-T IQ 
domain [36], [75]–[77], C-T EF-hand [72], [78]–[80], and fibroblast growth factor homologous 
factor (FHF) [34], [81]. It should be noted that observation of binding does not necessarily mean 
that there is a functional effect of that interaction. 
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 Much of the above controversy should be considered in light of technical challenges 
associated with these experiments. First, it is difficult to accurately measure intracellular calcium 
concentration. One reason for this is the use of calcium buffering reagents like ethylene glycol 
tetraacetic acid (EDTA) or 1,2-bis(0-aminophenoxy)-ethane-N,N,N’,N’-tetraacetic acid (BAPTA) 
to buffer calcium in the 0.5-10 μM range [82]. 0.5-10 μM is significantly above the dissociation 
constant for calcium and these reagents, which is approximately 100 nM [83]. When 10 mM 
calcium buffer is added with 10 mM calcium, calcium is virtually unbuffered. Second, the 
intracellular solution, in most experiments, contained cesium fluoride. While fluoride anions in the 
pipette solution can help with patch formation, these ions alter G-protein signaling in cells, a 
pathway that also regulates sodium channels [84], [85]. Third, when measuring SSI, time-
dependent voltage shifts equilibrate between breaking into the cell and the beginning of the 
recording, and kinetics of equilibration can vary, preventing precise quantification of calcium-
dependent effects on sodium current [65]. Finally, calcium delivery in the internal pipette solution 
makes it challenging to detect fast calcium-induced changes in current amplitude without an overt 
change in the voltage-dependence of activation or inactivation of the channel. Changes in current 
amplitudes may relate to either disrupted channel gating or trafficking and could arise from other 
cellular factors [82]. 
To overcome challenges in deciphering ion channel regulation by calcium and other agents, 
there is a real need to monitor conformational changes. Most have looked at electrophysiology, 
including peak currents and changes in SSI and SSA. Still, there needs to be a conformational 
readout, and fluorescence can provide that necessary dimension. Alternative approaches to 
biophysical characterization of sodium channels, such as live-cell fluorescence imaging, will help 
clarify our understanding of how channel structure imparts function in full-length channels 
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expressed in live cells. Due to the lack of reliable tools for labeling the Nav1.5 α subunit, its 
auxiliary subunits, and interacting partners, studying the molecular components involved in 
channel regulation by fluorescence imaging remains challenging. The remainder of Chapter 1 will 
discuss the state of the field of fluorescence imaging of ion channels with respect to state-of-the-
art microscopy and fluorescent labeling of proteins in live cells. 
1.6 Visualizing ion channels in live cells 
A primary question is: how do specific ion channel conformations impart function? Imaging of 
ion channels in live cells using fluorescence microscopy offers a complementary view of their 
structural dynamics compared to traditional mutagenesis and static structural characterization. 
Fluorescence is the emission of light resulting from absorption of higher energy light by a 
fluorophore. When the fluorophore absorbs light, a single electron is promoted to an excited state. 
When the electron decays to the ground state, it typically emits a photon which is of lower energy 
and longer wavelength than the absorbed light. However, deexcitation does not necessarily result 
in light emission. Nonradiative decay can occur through a variety of mechanisms. The electron 
can decay to an internal vibrational state, with excitation energy being lost as heat. Triplet-state 
quenching of the fluorophore occurs when the excited electron undergoes a forbidden transition to 
the triplet state. Nonradiative decay can also occur via intermolecular interactions. Nonradiative 
mechanisms prevent fluorescence and reduce the quantum yield (QY) of the fluorophore, defined 
as number of photons emitted/number of photons absorbed [86]. 
 How is fluorescence observed? A standard epifluorescence microscope contains an 
excitation light source, for example a mercury lamp or laser, and mirrors or lenses to focus light 
towards a detector. Excitation light is filtered and reflected off a dichroic mirror and through a 
lens. This results in a broad light beam focused on the sample, which excites fluorophores in the 
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sample. Excited fluorophores emit light at a longer wavelength, which is directed back through the 
lens, passing through the dichroic mirror, through an emission filter and directed to an eye-piece 
or camera for visualization. One limitation of epifluorescence microscopy is that scattered light is 
also collected, increasing the background. Confocal microscopy uses pinholes to focus excitation 
light on a smaller area of interest and focus emission light from that area, thus reducing the amount 
of scattered light. Accordingly, confocal microscopy can be used to image live cells with a signal-
to-noise ratio significantly higher than in epifluorescence. Total Internal Reflection Fluorescence 
Microscopy (TIRFM) builds upon confocal microscopy and is suited for imaging cell-membrane-
localized fluorophores. TIRFM takes advantage of the properties of an evanescent wave induced 
in the region at the interface of the cell membrane and coverslip, which have different refractive 
indices. Some disadvantages to fluorescence include limited optical resolution – the theoretical 
diffraction limit of a visible light microscope is on the order of 200 nm – and fluorophore 
photobleaching [87].  
 An early advance in surpassing the optical resolution limit was the invention of the electron 
microscope in 1931 by Max Knoll and Ernst Ruska at Berlin Technische Hochschule [88], [89]. 
Electron microscopy uses an electron beam as the illumination source, enabling resolution of sub-
cellular structures down to one nm [87]. One of the first images of purified sodium channels was 
taken on an electron microscope. In 1982, long twisting ribbons of clustered VGSCs purified from 
Electrophorus electricus were observed in negatively stained electron micrographs [90]. Since 
then, cryo-EM has been a key technique for structural elucidation of ion channels, but it is difficult 
to determine the functional significance of static structures depicted by that method. Furthermore, 
cryo-EM is not suitable for studies of proteins expressed in live cells – the combination of cold 
temperature, vacuum, and high energy electrons is a bit much for them. In theory, live-cell 
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fluorescence imaging can go beyond static imaging of membrane proteins, providing a dynamic 
complement to structural studies.  
Genetically encoded fluorescent labeling of ion channels for live cell imaging 
 
Fluorescence imaging of ion channels requires specific labeling with fluorescent dye molecule(s). 
This section details genetically encoded methods for fluorescent labeling of ion channels in cells. 
While there are many labeling options, this section will focus on fluorescent tagging of ion 
channels via genetic encoding of fluorescent proteins (FPs), small peptide and alternative protein 
tags, and fluorescent unnatural amino acids (UAAs)  
Fluorescent proteins 
 
The most common fluorescent labeling method for proteins in cells is genetically encoded fusion 
to a FP. Green Fluorescent Protein (GFP) was discovered in Aequorea victoria [91]. Wild-type 
GFP is a stable, proteolysis-resistant chain of 238 residues, has two absorption maxima at 
approximately 395 and 475 nm, and emits at a maximum of 508 nm with a QY of 0.72 to 0.85 
[91]. The fluorophore, p-hydroxybenzylidene-2,3-dimethylimidazolinone (HBDI) in its anionic 
form, is formed by an autocatalytic cyclization reaction of the polypeptide backbone between S65 
and G67 and oxidation of the α-β bond of Y66 [91]. Enhanced GFP (EGFP) is obtained by making 
the mutation S65T, which results in a single enhanced excitation peak at 488 nm [91]. 
Genetically encoded FPs are an easy, powerful tool for imaging a protein-of-interest (POI) 
in the cell. However, a drawback to FP labeling is their large size (27 kDa), making them 
impractical for labeling regions apart from protein termini. In addition, many classes of proteins 
are functionally perturbed by these large labels, even on their termini, in a way that is difficult to 
predict. For instance, N-terminal GFP labeled actin monomers tend to form excessive actin 
filaments, whereas C-terminal labeling has no effect [92].  
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 There has been confusion in the VGSC field as to whether GFP labeling of α subunits 
perturbs channel expression and function [93]. While VGSC channel α subunits have been labeled 
with GFP, the FP tag seems to exert varying effects on different VGSC subtypes. Choice of 
location for GFP insertion can also impact channel function. For instance, Ataka and Pieribone 
published that GFP labeling of Nav1.4 in X. laevis oocytes changed channel function, but it should 
be noted that GFP was inserted into short intracellular and extracellular loops [94]. FP labeled 
Nav1.8, a TTX-resistant channel typically expressed in sensory neurons, does not express in 
HEK293T – currents averaging less than 50 pA were observed – but can be expressed in HeLa 
cells [95], [96]. C-terminal and N-terminal FP labeled Nav1.8 was also functionally expressed by 
intranuclear injection of the cDNA into Rattus norvegicus superior cervical ganglion (SCG) 
neurons, suggesting that HEK293 cells lack factor(s) necessary for functional expression of this 
construct [96]. In SCGs, all constructs were functionally indistinguishable except the SSI curve 
for EGFP-Nav1.8 exhibited a significant shift of ~9 mV towards more depolarized potentials, 
compared to non-tagged Nav1.8. FP labeled Nav1.8 localized in a granule pattern inside SCGs, 
however, expression of FP labeled Nav1.8 in HeLa resulted in endoplasmic reticulum (ER)-
localized fluorescence. These data highlight the need for thorough characterization of FP labeled 
VGSCs in the desired cell line, because choice of cell line and target ion channel sub-type clearly 
impact functional labeled protein expression [96]. 
 In contrast, other work demonstrates that C-terminal FP labeling of Nav1.5 has no 
significant functional effect and could be used for studies of Nav1.5 trafficking and interactions in 
mammalian cells. Zimmer et al. fused GFP to the Nav1.5 C-T and expressed these channels in 
HEK293 [97]. Expression level, SSA, SSI, and kinetics of fast inactivation were not significantly 
affected by the GFP label [97]. Later, the same group used FP labeled Nav1.5 channels to 
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demonstrate that Nav1.5α binds β1 but not β2 in the ER and they traffic together to the plasma 
membrane [98].  Similar functional results with Nav1.5-EGFP were observed in HEK293T and X. 
laevis oocytes, but a N-terminal EGFP-Nav1.5 construct exhibited decreased expression compared 
with unlabeled Nav1.5, highlighting the importance of careful site selection for FP labeling [99].  
In all, since ion channels and other membrane proteins rely on N-terminal targeting 
sequences to get to the plasma membrane, N-terminal FP labeling is more likely to affect 
expression by interfering with trafficking [100]. Also, FP labeling of intramolecular regions is 
likely to perturb function. Other VGSC α subunits besides Nav1.5 are less tolerant of FP tags in 
heterologous cells, such as Nav1.8. In conclusion, very few generalizations can be made about the 
amenability of VGSC α subunits to FP labeling. Each labeled channel requires careful 
characterization of expression and function in the experimental cell line.  
Short peptide and alternative protein tags 
 
Short peptide and alternative protein tags offer a potentially smaller alternative to FPs for 
fluorescent labeling in live cells. These tags require encoding of a short peptide or small protein 
on the POI that binds or reacts with a fluorophore. For instance, the trimethoprim (TMP) tag has 
been modified for non-covalent, covalent, and fluorogenic labeling of proteins in mammalian cells 
[101]–[104]. TMP-tag has been demonstrated successfully for intracellular and membrane protein 
labeling, as well as super-resolution microscopy in live cells [105], [106]. The choice of tags in 
addition to TMP-tag, are the 6-10 amino acid FlAsH/ReAsH tag [107], [108], Lipoic Acid Protein 
(LAP) Ligase [109], [110], Oligo-Asp [111], BL-tag [112], SNAP/CLIP tag [113], [114], HALO 
tag [115], leucine zipper (ZIP) tag [116], photoactive yellow protein (PYP) tag [117], Dac tag 
[118], β-lactamase tag [119], Tub tag [120], [121], SpyTag [122], and a number of small epitope 
tags that can be labeled with fluorophore-conjugated antibodies [93]. In general, short peptide and 
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alternative protein tags have the advantage over FPs with respect to fluorophore modularity and, 
for short tags, regional flexibility. Short peptide tags, however, are not as flexible as unnatural 
amino acid mutagenesis with respect to site specificity.  
Unnatural amino acids 
 
To probe regions other than protein termini, smaller alternatives to FPs and short peptide tags have 
been sought for live-cell imaging studies. Unnatural amino acids (UAAs) are organic compounds 
consisting of amine and carboxy functional groups, along with a side chain that differs from that 
of the 20 naturally occurring amino acids, excluding pyrrolysine (Pyl) and selenocysteine, which 
are themselves considered “unnatural” due to their unique side-chains. UAAs add new 
functionality to the POI with minimal perturbation owing to their small size. In 1989, Robertson 
et al. published methodology for UAA incorporation into proteins by amber suppression via 
chemical aminoacylation of the hybrid dinucleotide 5’-phospho-2’-
deoxyribocytidylylriboadenosine (pdCpA) and subsequent ligation to truncated amber suppressor 
tRNACUA (-CA) using T4 RNA ligase [123]. Since then, fluorescent labeling of ion channels with 
UAAs has been performed primarily with pdCpA-ligated UAA-tRNAs in X. laevis oocytes. 
The first example of the UAA tRNA-ligation technique to probe structure-function in a 
membrane protein was in 1995, when Nowak et al. incorporated fluorinated tyrosine analogs into 
nicotinic acetylcholine receptors (nAChR) expressed in X. laevis oocytes via injection of pdCpA 
ligated tRNA and receptor mRNA containing an amber stop codon [124]. An advantage of this 
technique is the range of molecules that can be ligated to the amber suppressor tRNA. For instance, 
single-molecule imaging of Nav1.4 and ClC-0, a dimeric plasma membrane chloride channel, in 
X. laevis oocytes was achieved by genetic encoding of Cy3 and Cy5 UAAs via pdCpA ligation 
[125]. Time-resolved single-molecule imaging of Lys(BODIPYFL) UAA labeled nAChR 
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expressed in fixed X. laevis oocytes was performed by injecting frameshift suppressor tRNA-
Lys(BODIPYFL) and nAChR (α/β19’GGGU/γ/δ) mRNAs [126]. L-aladan, a fluorescent UAA, 
was directly incorporated into Shaker potassium channels in X. laevis oocytes by co-injection of 
L-aladan charged suppressor tRNA and channel cRNA containing an amber stop codon [127]. 
While fluorescent labeling was not performed, a unique method for expression of functional dual 
UAA-incorporated Shaker and Nav1.4 channels expressed in X. laevis oocytes was devised using 
inteins and chemically ligated UAA-tRNAs [128]. UAAs are independently incorporated into 
separate halves of the channel, each tagged with ERret-intein sequences [128]. Proximity-induced 
intein-dependent cleavage and formation of a peptide bond assemble full-length dual UAA-
incorporated channels, thus circumventing decreased expression associated with dual nonsense 
suppression in a single polypeptide [128]. This method should prove useful for dual fluorescent 
labeling of ion channels in the future. 
To bypass non-trivial pdCpA ligation chemistry, the mammalian aaRS-tRNA pair for the 
fluorescent UAA L-anap has been successfully expressed in X. laevis oocytes [129]. In the last 
five years, that aaRS-tRNA pair has allowed site-specific fluorescent labeling of a handful of ion 
channels for biophysical studies in X. laevis oocytes – glycine receptors, Shaker, and cyclic-
nucleotide gated α (CNGA1) channels – and in mammalian cells – transient receptor potential 
vanilloid (TRPV1) and human acid-sensing (hASIC1) channels [129]–[134]. Other ion channels 
have been incorporated with UAAs via aaRS-tRNA technology in mammalian cells. For example, 
to probe N-type inactivation of Kv1.4 channels, L-o-methyl-tyrosine (Ome) and L-dansylalanine 
(DanAla) were incorporated into Kv1.4 expressed in mammalian cells using their evolved aaRS-
tRNA pairs: OmeRS from E. coli TyrRS-TyrtRNACUA and DanAlaRS from E. coli LeuRS-
LeutRNACUA [135]. Recently, 7-hydroxycoumarin, a fluorescent UAA analog of tyrosine, was 
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incorporated into TRPV1 channels expressed in mammalian cells using a rationally designed 
aaRS-tRNA. With this method, direct optical measurements were made of channel activation by 
capsaicin [136], [137].  
While fluorescent labeling of ion channels by aaRS-tRNA technology is limited by the 
fluorescent UAAs and aaRS-tRNA pairs available, genetic encoding of a single fluorophore at a 
specific site in an ion channel remains an attractive goal. This method opens up fluorescent labeling 
of previously inaccessible non-terminal and intracellular ion channel sites in a way expected to 
minimally perturb function. 
Imaging ion channel conformational dynamics, interactions, and trafficking 
Once channels are fluorescently labeled, there are a handful of powerful imaging methods for 
measuring ion channel conformational dynamics, intermolecular interactions in cells, and 
intracellular ion channel recycling and trafficking. Förster Resonance Energy Transfer (FRET), 
Fluorescence Loss In Photobleaching (FLIP), and Fluorescence Recovery After Photobleaching 
(FRAP) are a few techniques discussed. These techniques provide complementary dynamic 
information to structural and electrophysiological studies; however, improved fluorescent probes 
and labeling chemistry are needed to make these techniques routine for the ion channel researcher. 
 FRET is a ruler for quantifying molecular interactions. With FRET, distances within 10 
nm between donor and acceptor fluorophores can be measured, depending on the electronic 
properties and fluorescence spectral overlap of the donor-acceptor pair [86]. Donor fluorophores 
are excited at the optimal donor excitation wavelength, and they transfer energy to acceptor 
fluorophores via nonradiative dipole-dipole coupling [86]. FRET is extremely sensitive to small 
changes in distance, because energy transfer efficiency is inversely proportional to the sixth power 
of the distance between donor and acceptor molecules [86].  
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FRET between donor and acceptor FPs encoded on two individual proteins can be a sensor 
of protein-protein interactions in live cells [138]. With this labeling method, FRET has been used 
to characterize ion channel interactions in cells. For example, Nav1.4 and Cav1.2 interactions with 
apoCaM and calcium/CaM were measured by FRET, which demonstrated the stoichiometry of 
these complexes in live mammalian cells. [139]. A live cell ensemble FRET approach revealed 
that FP tagged Nav1.5 hH1 α and β subunits associate in the ER prior to plasma membrane 
trafficking [140]. These FP tagged constructs had been previously characterized and the tag did 
not change VGSC function in HEK293T [97], [98]. FRET measurements between interacting 
regions within individual ion channel α subunits remain elusive. We can visualize interacting 
regions by cryo-EM, but cannot necessarily interpret the function associated with the interaction. 
Dynamic FRET measurements in cells would confirm those interactions in physiological context 
and, when combined with electrophysiology, would directly connect them to channel function.  
Fluorescence Loss in Photobleaching (FLIP) and Fluorescence Recovery After 
Photobleaching (FRAP) are methods for measuring movement of fluorescently labeled proteins in 
live cells. Both techniques involve bleaching fluorophores in a small area of the cell. In FLIP, after 
repeated bleaching events, fluorescence decrease outside of the bleached area is measured as 
unbleached fluorescently labeled proteins diffuse into the bleached area [141]. In FRAP, 
fluorescence increase in the bleached area is measured as unbleached fluorescently labeled 
proteins diffuse into the bleached area [141]. In one example, FRAP was employed to demonstrate 
protein kinase C (PKC)- and protein kinase A (PKA)-mediated trafficking of Nav1.5-EGFP in 
mammalian cells [99], [142]. A unique FRAP-FLIP method was used to quantify α-amino-3-
hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor trafficking to and exocytosis from 
dendritic spines in cultured neurons [143], [144]. These methods enable determination of 
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fluorescently labeled protein sub-cellular movement, restrictions on that movement, and exchange 
rates, but can be limited by proteins diffusing too rapidly, low photostability of fluorophores, and 
slow bleach or detection times [141].  
Simultaneous imaging and electrophysiology of ion channels 
Fluorescence imaging enables the measurement of ion channel conformational dynamics. 
Combined fluorescence imaging and patch-clamp electrophysiology correlates dynamic 
fluorescence measurements with functional characterization of ion channels. This section will 
summarize the progress made over half a century of simultaneous fluorescence imaging and 
electrophysiology to visualize ion channel conformational dynamics connected to specific ion 
channel function.   
 Voltage-clamp fluorometry (VCF) is the key technique used to correlate ion channel 
function with conformational change. VCF, as it is practiced today, was established in 1996, 
combining two-electrode voltage-clamp electrophysiology and epifluorescence imaging [145]. A 
precursor to VCF was the visualization of the AP using fluorescent dyes. In 1970, Franco Conti 
and Ichiji Tasaki reported two-electrode voltage-clamp of the squid giant axon, Loligo vulgaris, 
while imaging each of three fluorescent dyes intracellularly injected or perfused. Fluorescence 
intensity changes were measured in response to hyperpolarizing and depolarizing pulses [146]. 
Calcium imaging, pioneered by Roger Tsien, represents another precursor of VCF where spectral 
shifts in emission of selective calcium-sensitive dyes are imaged with crude voltage control [147]–
[152]. Calcium fluorophore sensors developed by Demuro and Parker and others have enabled 
optical patch clamping [153]–[156]. Calcium imaging has become a routine lab technique, often 
performed with genetically encoded FP-based FRET sensors to measure calcium handling in 
different cell lines and with expression of a variety of VGICs and mutants thereof [157]. 
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 VCF is commonly performed on X. laevis oocytes heterologously expressing fluorescent-
labeled ion channels. X. laevis oocytes are large, 1.0-1.3 mm in diameter at stage V and VI, 
allowing for microinjection of RNA for heterologous expression and a favorable surface-to-
detection volume ratio for fluorescence imaging [158]. These attributes result in a high signal-to-
noise ratio. Most fluorescent labeling schemes for VCF rely on cysteine labeling involving thiol-
maleimide coupling between the cysteine thiol side-chain and maleimide-tethered fluorescent dye. 
For this labeling technique, native cysteines must be removed, target sites mutated to cysteine, and 
the function of mutant channels must be tested for similarity to wild-type. Cysteine-labeling is 
generally limited to the extracellular side since this reaction is disfavored in the reducing 
environment inside the cell [159]. X. laevis oocytes are injected with RNA encoding the mutant 
channels and then labeled with a maleimide membrane-impermeant dye, such as 
tetramethylrhodamine (TMR)-maleimide. Then, intensity fluctuations are measured alongside 
changes in current as a reporter of associated conformational changes [145].  
 VCF has enabled impactful studies in the ion channel field. Mannuzzu et al., 1996 used 
VCF to correlate S4 movement and movement of the gating charge in the archetypal voltage-gated 
potassium channel, Shaker, providing the first direct evidence that S4 is the voltage sensor [145]. 
Additional examples include measurement of the immobilization of Nav1.4 voltage sensors of DIII 
and DIV, not DI and DII, during fast inactivation [160], cooperativity between voltage-gated 
hydrogen channel (Hv1) pore domains [161], the timing between ligand activation and channel 
gating in olfactory-type CNGA2 channels [162], and cAMP-dependent gating of 
hyperpolarization-activated cyclic nucleotide-gated (HCN) channels using a fluorescent cAMP 
analog [163]. Recently, VCF with tryptophan quenching in cut-open X. laevis oocyte recordings 
of Nav1.5α demonstrated modulation of the DIV VSD by non-covalently bound subunit β1, 
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whereas β3, also non-covalently bound, interacted with the DIII VSD [29]. In our laboratory, VCF 
and modeling experiments demonstrated altered kinetics of KCNQ1 voltage sensor movement 
underlying slowed channel deactivation associated with atrial fibrillation mutants S140G and 
V141M [164]. It was shown that KCNE1 mediated changes in pore movement and voltage sensor-
pore coupling to slow IKs deactivation [164].  
 In the past five years, VCF in X. laevis oocytes with the environmentally sensitive UAA 
L-anap has been used to study ion channel structural dynamics. For example, intracellular sites on 
S1 and S6 of Shaker potassium channels were site-specifically labeled with L-anap in X. laevis 
oocytes using the mammalian L-anapRS-LeutRNACUA pair [129]. Since then, L-anap VCF in X. 
laevis oocytes has been used to study partial agonism in glycine receptors [134], interactions 
between TRPV1 channels and the cell membrane [133], and voltage-dependent movement of the 
catalytic region of a voltage-sensitive phosphatase [132]. Kalstrup and Blunck are leading the 
charge to make L-anap VCF in X. laevis oocytes approachable and reproducible so that it becomes 
routine [165].  
 A handful of studies have employed fluorescence spectroscopy of patch-clamped 
mammalian cells. Since mammalian cells are on the order of 1000x smaller than X. laevis oocytes, 
high signal-to-noise is difficult to achieve. Therefore, it is crucial to have specific labeling with 
bright fluorophores, which is also difficult. Interestingly, as early as 1988, VCF-like experiments 
were carried out in cultured sensory neurons, measuring depolarization-induced changes in 
calcium flux by simultaneous microfluorimetry and whole-cell patch-clamp electrophysiology 
[166]. In 2004, fluorescence spectroscopy and TIRFM was combined with patch-clamp of Shaker 
and Bacillus halodurans sodium channels (NaChBac) in a thorough evaluation of these techniques 
for optimal simultaneous fluorescence and electrophysiological measurements in mammalian cells 
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[167]. The authors’ main technical issue with the fluorescence imaging was low signal-to-noise 
due to non-specific fluorescent labeling of external cysteines, a challenge which can now be 
addressed by improved site-specific fluorescent labeling methods [167]. 
Single-molecule imaging and electrophysiology of ion channels 
 
Single-molecule microscopy permits visualization of single protein localization and structural 
dynamics in cells. These imaging modalities distinguish mechanistic differences in heterogenous 
protein populations. Advantages of single-molecule imaging include: (1) measurement of a 
distribution of biomolecule behaviors, not only the ensemble average, (2) measurement of kinetics 
without needing to synchronize the entire population of molecules, and (3) detection of rare states 
that would be missed by ensemble averaging [168]. As single channel patch-clamp 
electrophysiology enables phenotypic characterization of sub-populations of a single type of 
mutant channel, imaging single channels could similarly identify structural motions associated 
with distinct populations within a heterogeneous channel population.  
Routine single-molecule imaging of membrane proteins, including ion channels, in cells is 
primarily a problem of methodology. The main hurdles to single-molecule imaging of ion channels 
in cells are the lack of easy non-perturbative labeling schemes, which might involve slow labeling 
and cell washing, and a lack of well-behaved bright dyes. Most single-molecule and super-
resolution techniques can resolve only one color, and many individual samples need to be 
measured to obtain sufficient data. This can be restrictive when working with cells, whose health 
and biology can change over the course of an experiment.  
Despite limitations, a handful of studies have made headway in single-molecule imaging 
of ion channels in cells, even combined with patch-clamp electrophysiology. For instance, in 
addition to the single-molecule studies of Nav1.4 and ClC-0 mentioned previously [125], NMDA 
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receptors with GFP-labeled NR1 and NR3 subunits expressed in X. laevis oocytes were counted 
at single-molecule resolution by photobleaching [169]. It should be noted, however, that single-
subunit counting by photobleaching of GFP-tagged subunits is hindered by high background 
fluorescence, poor control of expression, and low GFP maturation efficiency [169], [170]. Also in 
X. laevis oocytes, single-molecule imaging was used to demonstrate cooperativity of Streptomyces 
lividans pH-gated potassium channel (KcsA) gating [171], measure the stoichiometry of Stim and 
Orai subunits that form calcium-release-activated calcium (CRAC) channels [172], and measure 
voltage-dependent openings of individual Shaker potassium channels [173].  
Single-molecule experiments have also highlighted controversy surrounding the number 
of KCNE1 subunits that typically associate with a KCNQ1 pore-forming subunit. Single-molecule 
fluorescence bleaching was used to measure the relative stoichiometry of KCNQ1 and KCNE1 in 
X. laevis oocytes. In this system, KCNQ1 formed a tetramer and had flexible stoichiometry with 
up to four E1 subunits associating with up to four Q1 subunits [174]. In contrast, in mammalian 
cells, two E1 subunits and four Q1 subunits associated, and this ratio did not vary when E1 was 
raised or lowered 10-fold [175]. Why was there a discrepancy between mammalian cells and X. 
laevis oocytes? Channel function and biology can be different between mammalian heterologous 
systems and X. laevis oocytes, possibly because in mammalian cells, native protein assembly 
“rules [are] strictly obeyed” [170].  
Therefore, there is much interest in combining fluorescence measurements, ensemble or 
single-molecule, with electrophysiology in mammalian cells. To date, only a small number of 
single-channel imaging and electrophysiology studies have been published. In HEK293T cells, 
single-molecule patch-clamp FRET anisotropy revealed the kinetics of N-methyl-D-aspartate 
(NMDA) receptor activation and deactivation under ligand (glycine and glutamate) binding [176]. 
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In this study, single-channel currents, representing open-close conformational dynamics, and 
single-molecule anisotropy FRET, representing ligand binding and unbinding, were measured 
simultaneously [176]. Whole cell currents were measured in combination with single-molecule 
imaging of L-type calcium channels in mammalian cells [177]. Fluorescent ligand binding to 
nAChR in HEK293 cells with patch-clamp and single-molecule imaging has been demonstrated, 
but a lag between ligand binding and channel opening was observed for several thousand events, 
likely representing altered binding kinetics of the fluorescent ligand [178]. It is likely that more 
studies like these have not been published because of the labor-intensive and technically 
challenging nature of these experiments. These experiments usually require specialized built-in-
house imaging and electrophysiology setups and data from many single channels are needed to 
discern a biological result. 
The main barriers to simultaneous single-molecule fluorescence and electrophysiology 
measurement are: (1) There is an incompatibility between experimental requirements for single-
molecule fluorescence and single-channel electrical recording [168]. Single-channel 
measurements require a single channel present in a patch where a GΩ seal can be stably 
maintained, whereas for single-molecule imaging, if the patch contains only one fluorescently 
labeled channel, rapid photobleaching stops the experiment [168]. (2) There is a problem of 
correlating signals when more than one channel is present in the patch [168]. (3) In live cells, 
background fluorescence from membranes and intracellular structures and non-specific labeling 
of those structures present challenges [87]. (4) The chemistry of site-specific protein labeling in 
cells is not straightforward and the dyes are not usually bright or photostable enough for single-
molecule imaging of proteins expressed in cells [87]. While some advances have been made 
towards single-molecule imaging and electrophysiology of ion channels in mammalian cells, 
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improved dyes, labeling schemes, and imaging and data analysis interfaces are needed to gain the 
subtle insights on ion channel biophysical mechanism this type of experiment can offer.  
Two burgeoning modes of ion channel structure-function imaging in mammalian cells 
would positively impact the field. One, combined single-molecule fluorescence imaging with 
single-channel electrophysiology would permit characterization of single-channel phenotypes and 
their underlying structural mechanisms. Two, combined ensemble imaging of spectral shifts or 
FRET with whole-cell patch clamp electrophysiology would facilitate measurement of structure-
function of the ensemble channel population with a more sensitive signal than fluorescence 
intensity change. In particular, FRET could be used to map region-specific interactions correlated 
with functional changes of the channel. In the way that calcium imaging has become the go-to 
method for imaging APs on the confocal microscope, a general FRET assay for measurement of 
intramolecular ion channel interactions would enable routine dynamic visualization of ion channel 
structure-function. 
The goal is to answer how specific ion channel conformations impart function. A 
controversy in the eukaryotic VGSC field revolves around what channel regions constitute the 
inactivation complex and how they act together to regulate channel inactivation. In Chapter 1, 
imaging and electrophysiology techniques were described, which can be used to answer 
questions of ion channel structure-function. Chapters 2 and 3 describe an approach that builds 
upon these methods. Chapter 4 discusses overarching conclusions, implications, and limitations 
of this work, and Chapter 5 provides instructions on how to reproduce these experiments. Herein, 
site-specific genetically encoded fluorescent labeling and spectral imaging are applied to probe 
the Nav1.5 inactivation complex in channels expressed in mammalian cells.  
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2.1 Unnatural amino acid aaRS-tRNA technology in mammalian cells 
The following chapter describes proof-of-principle unnatural amino acid (UAA) incorporation 
experiments using synthetase-tRNA (aaRS-tRNA) technology in mammalian cells. First, the 
model UAA Nε-boc-L-lysine (NbocK) was incorporated in a model protein EGFP(Y40TAG). 
Next, two methods for site-specific fluorescent labeling of proteins were tested in mammalian 
cells: (1) direct incorporation of the fluorescent UAA L-anap (3-(6-acetylnaphthalen-2-ylamino)-
2-aminopropanoic acid) and (2) bioorthogonal labeling of a strained alkyne UAA BCNK 
(bicyclo[6.1.0]nonyne-L-lysine) via an inverse electron-demand Diels–Alder (IEDDA) reaction. 
Finally, Nav1.5 was tested for its amenability to NbocK incorporation, permissive UAA 
incorporation sites in the III-IV linker were determined, and the function of NbocK-incorporated 
channels was characterized by patch-clamp electrophysiology.     
In the 1980s, UAAs were first introduced into peptides by semi-synthesis [179]–[181]. 
Then, sense codons were re-coded in vitro when natural tRNAs were misacylated with UAAs by 
pdCpA ligation. For instance, E. coli PhetRNA was misacylated with N-acetyl-L-phenylalanine 
and could form dipeptide in an in vitro translation assay [182], [183]. E. coli PhetRNA has also 
been ligated to a photoactivatable analogue of phenylalanine, trifluoromethyl-diazirin-
phenylalanine, and it could be incorporated into peptides in an in vitro translation system [184]. 
Misacylated PhetRNA competes with the Phe-charged PhetRNA during translation, resulting in 
proteins containing both natural and unnatural amino acids [181]. Amber suppression was a key 
innovation towards abolishing this competition. Instead of recoding a sense codon, a nonsense 
codon (UAG) was encoded at the site of interest and tRNAs were engineered with a nonsense 
suppressor anticodon (AUC) [123].  
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Genetically encoded nonsense suppression in cells was made possible by engineered 
aminoacyl tRNA synthetases that ligate UAAs to amber suppressor tRNAs. Directed evolution in 
E. coli or S. cerevisiae is used to generate bioorthogonal aaRS-tRNA pairs specific to the UAA 
[185]. Co-translational mammalian cell incorporation of UAAs into proteins requires (1) a 
heterologously expressed bioorthogonal aaRS-tRNA pair, (2) a blank codon corresponding to the 
anticodon of the orthogonal tRNA, and (3) a UAA that can be introduced in the culture media and 
cross the cell membrane (Figure 2.1) [186]. The amino acid bound to the aaRS is activated by 
reaction with adenosine triphosphate (ATP), which forms an aminoacyl-adenylate and releases 
pyrophosphate. The adenylate-aaRS complex binds the corresponding tRNA and the 3’ or 2’-OH 
carboxyl on the last tRNA nucleotide – Adenosine 76 – nucleophilically attacks the activated 
aminoacyl-adenylate. This reaction forms the aminoacyl-tRNA with release of adenosine 
monophosphate (AMP). In the case of UAAs, an amber suppressor tRNA-UAA is formed by this 
reaction and is recognized by the cell’s endogenous translational machinery. At the ribosome, the 
amber suppressor tRNA binds an amber stop codon (UAG) encoded in the mRNA, and the UAA 
is incorporated into the growing polypeptide chain. 
 
Figure 2.1: UAA aaRS-tRNA technology. Unnatural amino acids (UAA) are charged to an 
orthogonal amber suppressor tRNA by an orthogonal aminoacyl tRNA synthetase, both expressed 
in mammalian cells. The UAA is incorporated by the cell’s endogenous ribosomes in response to 
an amber stop codon (UAG) encoded in the mRNA for the protein of interest (POI). 
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Two main advantages of UAA aaRS-tRNA technology are (1) the small size of a single 
amino acid probe allows minimal perturbation of protein function, and (2) genetic encoding of a 
nonsense codon permits specific incorporation at almost any non-terminal site. The incorporated 
UAA can offer an independent readout, such as fluorescence, of protein function and interactions. 
Fluorescent UAAs are significantly smaller than FPs (one amino acid vs. ~240 amino acids), and 
thus, are unlikely to perturb protein function. Fluorescent labeling with UAAs can be achieved by 
two methods: direct incorporation of a fluorescent UAA or labeling by bioorthogonal reaction of 
an incorporated click UAA with a complementary click fluorescent dye.  
Herein, both methods are attempted towards future studies of membrane protein 
conformational dynamics and interactions in cells. Experiments were performed based on three 
literature-reported examples: (1) incorporation of NbocK into EGFP(Y40TAG) via expression of 
the wild-type Methanosarcina mazei (Mm) PylRS-PylT pair [187], (2) direct incorporation of L-
anap into FP reporters [188], and (3) incorporation of a lysine click analog BCNK and subsequent 
tetrazine (Tz)-fluorophore ligation via an IEDDA reaction [186]. Fluorescent labeling of click 
UAAs by Tz-fluorophore ligation has gained traction as an alternative to direct incorporation of a 




Figure 2.2: Fluorogenic labeling of proteins by IEDDA reaction with click UAAs. 
Technical limitations have prevented routine use of UAA mutagenesis by biologists. One 
limitation to aaRS-tRNA technology is that the introduced amber stop codon can also be 
recognized by the cell’s endogenous translation termination machinery, resulting in a population 
of truncated proteins [199]. As a result, UAA-modified protein expression is significantly 
decreased compared with wild-type protein expression. Similarly, if the amber stop codon is close 
to the N-terminus, translation initiation machinery may prevent UAA incorporation and cause re-
initiation at downstream start codons [130]. This complication results in a population of potentially 
functional proteins without incorporated UAA, thus convoluting measurements of UAA-
incorporated protein function. 
34 
 
In contrast to the UAAs that can be incorporated by pdCpA ligation, there is a lack of 
diversity in UAAs that can be incorporated with aaRS-tRNA pairs. Substrate diversity is inherently 
limited by the synthetase binding pocket. Only a few aaRS-tRNA pairs have been reliable 
substrates for directed evolution and transfer to higher organisms, and in most cases, a new aaRS-
tRNA must be generated for each UAA. The most common aaRS-tRNA pairs used as substrates 
for directed evolution are the E. coli leucine, Methanococcus jannaschii and E. coli tyrosine, M. 
jannaschii methionine, and Methanosarcina mazei (Mm) or Methanosarcina barkeri (Mb) Pyl 
synthetases [200]. Pyl is an exceptional case, since this amino acid is naturally incorporated by 
amber suppression in methanogenic archaebacteria [201]. While PylRS has been the most flexible 
to altered specificity of its binding pocket [202]–[204], advances in synthetase engineering and 
directed evolution are still needed to increase the diversity of UAAs that can be incorporated [205]. 
Synthetases have yet to be generated for large complex UAAs, such as bright fluorophores useful 
for single-molecule imaging. Computational modeling of synthetase binding pockets and 
mutagenesis thereof could aid rational design of synthetases for a greater variety of UAAs. An 
example in that direction is that an aaRS-tRNA pair was rationally designed for 7-
hydroxycoumarin in silico, allowing for incorporation of that UAA into GFP reporter proteins in 
mammalian cells [136]. 
Advances in aaRS-tRNA technology have been made towards improved UAA 
incorporation in mammalian cells and higher organisms. For instance, site-specific dual 
incorporation of UAAs can be achieved by incorporation of one UAA at an amber codon and 
another UAA at an ochre or opal stop codon [206]–[208] or at a quadruplet codon, which requires 
co-expression of orthogonal ribosomes [209]–[217]. About a handful of examples use aaRS-tRNA 
pairs for dual UAA incorporation in proteins expressed in cells – four in E. coli with subsequent 
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purification [214], [218]–[221] and one in mammalian cells [222] – but expression of dual-
incorporated proteins is decreased compared to that of single-incorporated proteins [217]. Genetic 
code expansion in higher organisms, such as Caenorhabditis elegans [223], Drosophila 
melanogaster [224], and Mus musculus [225], has been achieved, but has not seen widespread use. 
Chapter 2 reports validation of proof-of-principle UAA incorporation experiments with aaRS-
tRNA pairs in mammalian cells, testing of direct incorporation and bioorthogonal click chemistry 
methods of fluorescent UAA labeling of proteins, and determination of the amenability of Nav1.5 
to UAA mutagenesis. 
2.2 Results 
Nε-boc-L-lysine incorporation into EGFP in mammalian cells 
As a proof-of-principle, model UAA Nε-boc-L-Lysine (NbocK) was incorporated into 
EGFP(Y40TAG) in mammalian cells and fluorescence was observed by confocal imaging and 
flow cytometry (Figure 2.3). These experiments require co-expression of the Mm PylRS-PylT and 
EGFP(Y40TAG) or wild-type EGFP in HEK293T cells grown ±1 mM NbocK (Figure 2.3A). 
Wild-type EGFP was highly expressed in these cells, and the number of GFP expressing cells 
reached approximately 77% of the total population (10,000 cells) (Figure 2.3B, Right, wild-type). 
For EGFP(Y40TAG), NbocK-dependent EGFP expression resulted in approximately 33% EGFP-
positive cells (Figure 2.3B, Left, +NbocK). Since very little EGFP fluorescence was observed in 
the absence of NbocK, the Mm PylRS-PylT aaRS-tRNA pair is specific for NbocK incorporation 
in this system (Figure 2.3B, Middle, -NbocK). These data suggest successful incorporation of 





Figure 2.3: Incorporation of Nε-boc-L-lysine into model FP reporter protein EGFP(Y40TAG). (A) 
Chemical structure of NbocK and constructs for NbocK incorporation, including the M. mazei 
PylRS-PylT and EGFP(Y40TAG). (B) Fluorescence imaging (ex488, em525/50 nm) and flow 
cytometry results comparing EGFP expression ±1 mM NbocK with wild-type EGFP expression 
in HEK293T cells. 
Site-specific fluorescent labeling of model proteins in mammalian cells by direct incorporation of 
environmentally sensitive fluorescent UAA L-anap  
Once UAA incorporation in mammalian cells was established, I tested the L-anap aaRS-tRNA pair 
for site-specific fluorescent labeling of a nuclear-FP protein reporter. HEK293T cells were co-
transfected with H2B(V129TAG)-mCherry and L-anapRS-LeutRNACUA ±10 μM L-anap (Figure 
2.4). When imaged by confocal microscopy, nuclear-localized L-anap and mCherry fluorescence 
was observed in cells grown +L-anap. It should be noted that some non-nuclear-localized L-anap 
fluorescence was observed, suggesting non-specific L-anap labeling via binding to intracellular 
structures or incorporation at other amber stop codons. In addition, low mCherry fluorescence was 
observed in some L-anap negative cells, suggesting (a) L-anap incorporation, but at such a low 
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efficiency that L-anap fluorescence was too low to observe, (b) L-anap independent expression of 
the mCherry reporter either by amber stop codon readthrough or independent initiation of mCherry 
expression. In the absence of L-anap, no fluorescence was observed in the L-anap channel and dim 
fluorescence was observed in the mCherry channel, indicating that L-anap independent reporter 
expression occurred at a low level in this experiment. These imaging data suggest that aaRS-tRNA 
technology can be used to fluorescently label an intracellular protein in mammalian cells.  
 
Figure 2.4: Incorporation of L-anap into model FP reporter protein in mammalian cells. HEK293T 
were co-transfected with H2B(V129TAG)-mCherry reporter and E. coli L-anapRS-LeutRNACUA 
±10 μM L-anap. L-anap (ex405, em445/50 nm) and mCherry (ex555, em647/70 nm) fluorescence 
were imaged. Images in the first and fourth columns were taken at 20x magnification and images 
in the second and third columns were taken at 100x magnification. 
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Incorporation of a click UAA BCNK for site-specific fluorescent labeling of membrane proteins in 
mammalian cells 
Site-specific fluorescent labeling by click chemistry is an attractive option for labeling with bright 
fluorophores suitable for single-molecule imaging or FRET. A click lysine analog BCNK was 
incorporated into a membrane protein epidermal growth factor receptor-FP reporter, 
EGFR(N128TAG)-EGFP, for labeling with Tz-TAMRA via an IEDDA reaction in HEK293 cells 
[191]. BCNK incorporation was tested in EGFR(N128TAG)-EGFP co-expressed with Mm 
PylRS(Y306A/Y384F)-PylT (PylRSAF-PylT) in HEK293T cells (Figure 2.5A). The two 
mutations in wild-type PylRS to make PylRSAF open up the synthetase binding pocket, allowing 
for incorporation of larger ring structures, such as BCNK, trans-cyclooctene-L-lysine (TCOK), 
and norbornene-L-lysine (NORK) [203]. EGFP fluorescence was observed in the presence of 
BCNK and small EGFP signal was observed in the absence of BCNK (Figure 2.5B). 
Based on expression of the EGFP reporter, BCNK-incorporated EGFR protein was 
expressed, but non-specific labeling with Tz-TAMRA was observed (Figure 2.5B). Non-specific 
Tz-TAMRA labeling could reflect reaction of Tz-TAMRA with BCNK that remained on the cell 
surface despite washing the cells. More experiments are needed to find the optimal click UAA-Tz-
fluorophore pair. Commercially available Tz-dyes are currently limited to the least reactive 
molecules; more reactive Tz-dyes were employed in published reports [191]. Published molecules 
were synthesized in-house and the synthesis is non-trivial, making this technique difficult to 
reproduce. The molecular character of the UAA and the Tz-dye clearly impacts whether 





Figure 2.5: EGFR(N128TAG)-EGFP BCNK incorporation and Tz-TAMRA labeling. (A) M. 
mazei PylRSAF-PylT and EGFR(N128TAG)-EGFP or EGFR-EGFP were co-transfected in 
HEK293T ±0.25 mM BCNK, then labeled with Tz-5-TAMRA (B) EGFP (ex488, em525/50 nm) 
and TAMRA (ex555, em575-640 nm) fluorescence were imaged at 20x magnification. All EGFP 
and TAMRA image brightnesses were adjusted equally to aid visualization. Overlay image 
saturation intensities were increased equally to aid visualization.  
Nε-boc-L-lysine incorporation into Nav1.5 in mammalian cells 
 
Towards fluorescent UAA labeling of the Nav1.5 inactivation gate in mammalian cells, 
experiments testing if the Nav1.5 III-IV linker is amenable to model UAA NbocK incorporation 
were performed. The general scheme for incorporation of the UAA (amino acid with gold star) 
into the Nav1.5 α subunit inactivation gate is shown (Figure 2.6). The incorporation event competes 
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with natural termination of protein at the amber stop codon, creating a significant population of 
truncated target protein. In the case of Nav1.5, truncated channels have not formed the final pore 
loop and, therefore, are expected to be non-functional. 
 
Figure 2.6: Schematic of UAA incorporation in Nav1.5 III-IV linker. Expression of an orthogonal 
aminoacyl tRNA synthetase charges the co-expressed amber suppressor tRNA with UAA in 
mammalian cells. NbocK (amino acid with yellow star) is incorporated by the wild-type M. mazei 
PylRS-PylT pair [187]. UAA-charged amber suppressor tRNA interacts with endogenous 
ribosomes and can be added to the peptidyl chain in response to an amber stop codon (UAG). 
Amber stop codons were introduced into the III-IV linker of SCN5A-EGFP and tested for 
incorporation of NbocK using EGFP as a reporter of full-length channel expression in HEK293T 
cells (Figure 2.7). Seven sites in the proximal III-IV linker were tested for NbocK incorporation: 
F1472, N1473, Q1475, K1478, D1483, I1484, and F1485. EGFP fluorescence reported on the 
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expression of full-length SCN5A-EGFP fusion protein and was assayed by flow cytometry (Figure 
2.7A). SCN5A(TAG)-EGFP expressed in the presence of NbocK (Figure 2.7C), compared to 
SCN5A-EGFP (Figure 2.7B), existed in one broadly distributed population with respect to EGFP 
fluorescence intensity. In the absence of NbocK, all conditions existed in the low or no EGFP 
population near the boundary, which was drawn based on non-transfected cells (Figure 2.7B). 
Cells expressing the reporter in the presence of NbocK were between 30 and 40% of the population 
(10,000 cells total). The number of EGFP fluorescent cells was highest in the case of Q1475TAG 
(~40%). Thus, this mutant was chosen for further study. In the absence of NbocK, cells expressing 
the reporter were between 20% and 35% of the population, overlapping that of the +NbocK 
population. While the number of fluorescent cells did not change drastically in the presence of 
NbocK, there was a shift towards increased EGFP fluorescence intensity in cells that were 
expressing. This experiment suggests that the III-IV linker sites tested are permissible for UAA 







Figure 2.7: Flow cytometry of SCN5A(TAG)-EGFP with Nε-boc-L-lysine incorporation. (A) 
Schematic of NbocK incorporation experiment in SCN5A-EGFP III-IV linker. (B) Flow cytometry 
data of wild-type SCN5A-EGFP expressing HEK293T and non-transfected HEK293T. y-axis is 
EGFP fluorescence, x-axis is forward scatter height, a measure of cell size. (C) Flow cytometry 




Functional characterization of Nε-boc-L-lysine-incorporated Nav1.5 in mammalian cells 
Functional sodium channel expression was dependent on the presence of 1 mM NbocK. HEK293T 
cells were co-transfected with target SCN5A(Q1475TAG), Mm PylRS-PylT pair, and 
EGFP(Y40TAG), and grown ±1 mM NbocK (Figure 2.8A). EGFP(Y40TAG) served as a 
fluorescent marker of cells that could successfully undergo UAA incorporation. Representative 
traces demonstrate that sodium current was dependent on the presence of NbocK, and little to no 
sodium current was observed in the absence of NbocK (Figure 2.8B). Peak current density of 
channels expressed +NbocK was approximately half the average wild-type current densities 
(Figure 2.8C). Significantly decreased peak current density was observed in the absence of NbocK 
(Figure 2.8C), suggesting that channel expression depended on the presence of NbocK and these 
are full-length channels with NbocK incorporated at Q1475TAG. 
Inactivation kinetics were unchanged by incorporation of NbocK at Q1475TAG, since 
there was no significant difference in the time to half-complete inactivation (t1/2) (Figure 2.8D), 
but TTX-sensitive data are needed to look at the possible effect of NbocK incorporation on late 
current and steady-state inactivation. Decreased peak current density is likely due to a combination 
of defective trafficking to the plasma membrane, lower channel expression, or a decrease in single 
channel conductance. Lower expression in these systems is expected since UAA incorporation at 
the amber stop codon competes with natural translation termination. Lower expression may be 
compounded by a defect in UAA-incorporated channel trafficking to the membrane due to the 




Figure 2.8: Patch-clamp electrophysiology of Nε-boc-L-lysine-modified Nav1.5 channels. (A) 
HEK293T transfection conditions. (B) Representative capacitance-normalized current traces from 
cells incubated ±1 mM NbocK or expressing wild-type channels. Inset is the voltage protocol. (C) 
Average peak current density (pA/pF) for all conditions. *p<0.05, single-factor ANOVA. (D) time 
to half-complete inactivation (t1/2, ms), ns, Student’s t-test. 
2.3 Summary of UAA mutagenesis of proteins in mammalian cells 
Chapter 2 describes proof-of-principle UAA incorporation experiments using aaRS-tRNA pairs in 
mammalian cells. First, the model UAA NbocK was incorporated into a model protein 
EGFP(Y40TAG) (Figure 2.3). Next, two methods were tested for site-specific fluorescent UAA 
labeling of model proteins: (1) direct incorporation of the environmentally sensitive fluorescent 
UAA L-anap, which demonstrated sufficiently specific labeling of an intracellular fluorescent 
reporter (Figure 2.4), and (2) bioorthogonal labeling of a click UAA BCNK via an IEDDA reaction 
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with Tz-TAMRA, which demonstrated non-specific cell surface labeling (Figure 2.5). Finally, all 
Nav1.5 III-IV linker sites tested were permissible to NbocK incorporation (Figure 2.7) and NbocK-
incorporated channels were functional (Figure 2.8). Moving forward, direct L-anap labeling of the 
permissive site Q1475TAG is a one-step, commercially available option for making a fluorescent 
sensor of Nav1.5 III-IV linker conformational change in mammalian cells.
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Chapter 3 Genetic encoding of a site-specific fluorescent sensor of human cardiac voltage-




3.1 L-anap, a unique intracellular fluorescent label  
The characteristic ultraviolet fluorescence of natural amino acids tyrosine, tryptophan, and 
phenylalanine was first characterized in 1956, even though fluorescent analogs of these natural 
aromatic amino acids had been noted almost fifty years prior [226]. Fluorescent UAAs have been 
directly incorporated into proteins by solid-phase peptide synthesis since the 1960s. In 1967, Stryer 
and Haughland synthesized dansylated poly-L-proline oligomeric peptides for FRET studies 
[227]. Weber and Farris first synthesized prodan (6-propionyl-2-(N,N-
dimethyl)aminonaphthalene) in 1979 [228]. In 2002, Cohen et al. synthesized a prodan analogue, 
L-aladan (2-amino-4-(6-(dimethylamino)naphthalen-2-yl)-4-oxobutanoic acid) and incorporated 
it into potassium channels (Kir2.1, Shaker) and streptococcal proteins by pdCpA ligation and 
amber suppression [127].  
Since then, prodan analogues have been synthesized and aaRS-tRNA pairs have been 
evolved for fluorescent UAA mutagenesis of proteins in cells (Figure 3.1). For example,  
aaRS-tRNA pairs have been evolved for fluorescent UAAs L-anap (3-((6-acetylnaphthalen-2-
yl)amino)-2-aminopropanoic acid), L-nap (2-amino-3-(naphthalen-2-ylamino)propanoic acid), 
and L-dansylalanine (2-amino-3-((5-(dimethylamino)naphthalene)-1-sulfonamido) propanoic 
acid) in S. cerevisiae based on E. coli LeuRS-LeutRNACUA [188], [229]. L-dansylalanine, L-anap, 
and L-nap have been incorporated into human superoxide dismutase in S. cerevisiae [229], [230], 
and L-anap was incorporated into nuclear-, ER-, and Golgi-resident proteins in mammalian cells 
[188]. Synthetase-tRNA pairs have also been evolved for fluorescent UAAs L-8-
hydroxyquinoline-alanine (2-amino-3-(8-hydroxyquinolin-3-yl)propanoic acid), a metal chelating 
UAA [231], and L-7-hydroxycoumarin-ethylglycine (2-amino-4-(7-hydroxy-2-oxo-2H-chromen-
4-yl)butanoic acid) [136], [232] based on the M. jannaschii TyrRS-TyrtRNACUA pair. Since the L-
48 
 
anapRS-LeutRNACUA pair had been published in mammalian cells, L-anap labeling of a 
mammalian nuclear-FP reporter was validated in Chapter 2 (Figure 2.4) [188]. In Chapter 3, L-
anap is developed as a reporter of conformational rearrangement of the Nav1.5 III-IV linker. 
 
 
Figure 3.1: Examples of fluorescent UAAs based on prodan, including L-anap 
 L-anap has an extinction coefficient of 17,500 cm-1M-1 and a QY of 0.48 in ethanol [229]. 
L-anap is optimally excited at 365 nm, but can be excited at 405 nm, and displays solvatochromic 
fluorescence ranging from 480 nm in cells to 420 nm in organic solvent [188], [229], [233]. 
Experiments in S. cerevisiae revealed the nature of L-anap solvatochromism. L-anap was 
incorporated into the E. coli glutamine-binding protein and purified [229]. L-anap blue-shifted 50 
nm upon titration with glutamine [229]. Anisotropy experiments before and after glutamine 
binding revealed that the rotational configuration of L-anap was unchanged, suggesting the 
mechanism of environmental sensitivity is polarity changes in the local environment [229]. L-anap 
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exhibits positive solvatochromism – fluorescence emission red-shifts in polar environments and 
blue-shifts in hydrophobic environments [229], [234].  
The general electronic basis of positive solvatochromism is depicted in Figure 3.2 [235]. 
Prior to excitation, the fluorophore, surrounded by solvent molecules, is at the lowest energy state 
S0. Upon excitation, photon absorption boosts an electron to an excited singlet state S1, increasing 
the dipole moment. Solvent molecules reorient to accommodate the larger dipole moment, a 
phenomenon called solvent relaxation. Solvent relaxation lowers the energy of the excited singlet 
state and destabilizes the ground state, resulting in a narrower S1-S0 energy gap and longer 
wavelength of emitted light (red-shift). Decreasing solvent polarity decreases the amount of 
solvent relaxation [235]. Therefore, more hydrophobic environments result in a larger S1-S0 
energy gap and blue-shifted emission. Another mechanism of solvatochromism is intermolecular 
electron transfer, which occurs during hydrogen bonding and causes solvatochromism by solvent 
stabilization of the excited state’s larger dipole [234], [236]. Ultimately, solvatochromism relies 
on the difference in dipole moment between the ground and excited states [86]. 
L-anap solvatochromism arises from a combination of mechanisms imparted by the 
functional groups attached to the L-anap aromatic side-chain (Figure 3.1). The secondary amine 
and acetyl carbonyl oxygen participate in the aromatic side-chain π conjugated network, the length 
of which can extend or shorten depending on dipole-dipole and intermolecular transfer interactions 
with solvent [86], [236], [237]. Without molecular modeling, it is difficult to predict the change in 
dipole moment between L-anap’s ground and excited states that would determine the direction and 
magnitude of L-anap spectral shifts. Nonetheless, the solvatochromic properties of L-anap can be 




Figure 3.2: Positive solvatochromism Jablonski diagram. Adapted from Loving et al., 2010 [235]. 
Since the first demonstration of L-anap labeling of model proteins in S. cerevisiae and 
mammalian cells by Lee et al. and Chatterjee et al., respectively, there have been a handful of 
examples using L-anap environmental sensitivity to study proteins in X. laevis oocytes, S. 
cerevisiae, and mammalian cells [188], [229]. In 2013, Kalstrup and Blunck demonstrated VCF 
of L-anap labeled Shaker potassium channels in X. laevis oocytes and have published video 
protocols for reproducing L-anap VCF experiments [129], [165]. L-anap spectral shifts were used 
to monitor protein misfolding of luciferase in S. cerevisiae [238]. In X. laevis oocytes, glycine 
receptors, CNGA1 channels, and voltage-sensing phosphatases have been labeled with L-anap 
[131], [132], [134]. When CNGA1 channels were labeled, L-anap was used to measure interactions 
between channels and the cell membrane by transition metal FRET (tmFRET) [131].  Zagotta et 
al. demonstrated tmFRET between L-anap incorporated in TRPV1 channels and mammalian cell 
membranes, but cells were unroofed, presumably to increase fluorescence signal [133]. In CHO 
cells, L-anap was incorporated into hASIC1a and increasing concentrations of the channel toxin 
51 
 
mambalgin-1 were detected spectrally by a red-shift in L-anap fluorescence [239]. Recently, L-
anap was demonstrated as a FRET donor to EGFP in a FP-reporter fusion protein expressed in 
mammalian cells; FRET was abolished with proteolysis of the reporter [233]. Based on literature-
reported examples of L-anap environmental sensing in cells, I hypothesized that L-anap can act as 
a fluorescent reporter of III-IV linker conformational rearrangement in Nav1.5 expressed in 
mammalian cells. A general assay was developed to address three questions: (1) can L-anap sense 
local environment of the III-IV linker when incorporated at different sites? (2) can L-anap detect 
the absence of the distal C-T (DCT)? and (3) can L-anap detect conformational rearrangement of 
the III-IV linker between closed and open-inactivated states?  
3.2 Results 
L-anap incorporation and characterization of SCN5A(TAG)-FP expression 
Can the Nav1.5 III-IV linker be fluorescently labeled with environmentally sensitive UAA L-anap? 
As a reporter of full-length channel expression, EGFP or mCherry, was fused to the Nav1.5 C-T 
(Figure 3.3A). Full-length L-anap-dependent expression of SCN5A(Q1475TAG)-EGFP (~275 
kDa) was measured by western blot (Figure 3.3B). In the presence of L-anap, a characteristically 
smeared band was observed at ~275 kDa, corresponding to the more intense positive control band 
of the same size, representing full-length SCN5A-EGFP. Even though background was higher on 
some parts of the membrane than others, no band was observed in the absence of L-anap. The 
positive control for UAA incorporation was to incorporate L-anap into EGFP(Y40TAG). L-anap 
dependent full-length expression of EGFP was observed at ~25 kDa, corresponding to the band 
from cells expressing wild-type EGFP. No band was observed in the absence of L-anap. These 
results demonstrate L-anap-dependent expression of full-length sodium channel reporter proteins 
in mammalian cells. 
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 In Chapter 2, Nav1.5 III-IV linker sites were tested for permissibility to NbocK 
incorporation by flow cytometry (Figure 2.7). A site upstream in the III-IV linker Q1475TAG was 
chosen for L-anap incorporation because high expression of that reporter +NbocK was observed 
and the location of this site near a known LQT3 mutation F1473C suggested it would play an 
important role during inactivation [2]. HEK293T cells co-transfected with SCN5A(Q1475TAG)-
mCherry and L-anapRS-LeutRNACUA ±10 μM L-anap were imaged by confocal microscopy 
(Figure 3.3C). In the +L-anap condition, L-anap and mCherry fluorescence was observed at the 
plasma membrane and localized to intracellular compartments. This was expected due to literature 
reporting that Nav1.5 trafficking to the membrane is defective in the absence of β subunits [16]. 
The observed intracellular localization and potential trafficking defects of these channels are 
addressed in Chapter 4, Limitations.  
As a negative control, wild-type SCN5A-mCherry and L-anapRS-LeutRNACUA were co-
expressed in HEK293T +10 μM L-anap (Figure 3.3C). Bright mCherry fluorescence and dim L-
anap fluorescence was observed, but L-anap signal was significantly decreased compared to the 
condition in which channels encode the target amber stop codon. As a negative control to evaluate 
L-anap independent expression of the reporter protein, SCN5A(Q1475TAG)-mCherry was 
expressed in the presence of L-anapRS-LeutRNACUA in HEK293T grown without L-anap (Figure 
3.3C). Cell auto-fluorescence and dim mCherry signal were observed, but both signals were 
decreased compared to the condition where target protein was expressed +L-anap. Together, these 
data demonstrate L-anap-dependent Nav1.5(Q1475TAG) expression, suggesting that L-anap can 
be incorporated into the inactivation gate. Furthermore, L-anap fluorescence signal can be 




Figure 3.3: Incorporation of L-anap in Nav1.5 inactivation gate. (A) Schematic of Nav1.5-EGFP 
and L-anap. (B) Western blot of protein products of SCN5A(Q1475TAG)-EGFP and 
EGFP(Y40TAG) grown in HEK293T ±10 μM L-anap, probed with rabbit pAb-GFP. (Left) 
SCN5A-EGFP, 5% SDS-PAGE, 5 min exposure. (Right) EGFP, 10% SDS-PAGE, 1 min 
exposure. Each image in its entirety was adjusted for contrast and brightness enhancement. All 
conditions were co-transfected with L-anapRS-tRNALeuCUA. Full-length EGFP is ~27 kDa. Full-
length Nav1.5-EGFP is ~275 kDa. (B) Fluorescence imaging of HEK293T transfected with 
SCN5A(Q1475TAG)-mCherry or SCN5A-mCherry, L-anapRS-LeutRNACUA ±10 μM L-anap. L-
anap (ex405, em445/50 nm) and mCherry (ex555, em647/70 nm) fluorescence were imaged. All 
images were equally adjusted in their entirety for contrast and brightness enhancement. Images in 
columns 1, 3, and 4 were taken at 20x magnification. Images in column 2 were taken at 63x 
magnification. 
 
L-anap and other prodan analogues show good photostability in solution [237]. 
Furthermore, L-anap is photostable when imaged in mammalian cells (Figure 3.4). L-anap 
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fluorescence intensity in the SCN5A(Q1475TAG) + L-anapRS-LeutRNACUA +10 μM L-anap 
condition was measured in a time series with repeated excitation at 405 nm. A single exponential 
fit to the intensity data gives the characteristic time of photobleaching, which is 5000s, or 80 
minutes [240]. Experimental measurements were taken over times well under 80 minutes, thus L-
anap did not bleach significantly during live-cell imaging experiments. 
 
Figure 3.4: L-anap photostability in cells. Conditions in which Nav1.5(Q1475TAG) was co-
expressed with L-anapRS-LeutRNACUA in HEK293T grown in the presence of 10 μM L-anap were 
repeatedly excited and fluorescence intensity was measured over time (ex405, em445/50 nm).  
Electrophysiological characterization of Nav1.5 channels expressed in the presence of L-anap 
What are the functional characteristics of Nav1.5(TAG) channels expressed with L-anap? Patch-
clamp electrophysiology was performed on HEK293T grown ±10 μM L-anap and co-transfected 
with SCN5A(Q1475TAG), L-anapRS-LeutRNACUA, and EGFP(Y40TAG) (Figure 3.5). 
EGFP(Y40TAG) served as a marker of cells able to carry out UAA incorporation. In +L-anap 
conditions, TTX-sensitive sodium currents were observed in EGFP-positive cells (Figure 3.5A), 
although peak current density was significantly decreased compared to wild-type channels (Figure 
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3.5C). Decreased peak current density of L-anap labeled channels could be due to defects in 
channel trafficking to the plasma membrane, lower channel expression, or a decrease in single 
channel conductance.  
 Notably, small or no currents were observed in cells expressing all components for L-anap 
incorporation but grown in the absence of L-anap (Figure 3.5A,C). This suggests that sodium 
currents observed in the presence of L-anap are dependent on L-anap incorporation and represent 
full-length Nav1.5(Q1475L-anap) channels. Next, the inactivation properties of Nav1.5(Q1475L-
anap) channels were characterized. There was increased late current (INa,L) (Figure 3.5B) and 
lengthened time to half-complete inactivation (t1/2) (Figure 3.5D) in cells expressing 
Nav1.5(Q1475L-anap). The SSI curve, a measure of voltage-dependent transitions between the 
closed and closed-inactivated states, was shifted towards more depolarized potentials, suggesting 
destabilized inactivation and thus, an increase in availability of these channels to open and 
inactivate (Figure 3.5E). Together, electrophysiological data suggest that L-anap can be 
incorporated at Q1475TAG in the Nav1.5 inactivation gate, and while channel function is different 




Figure 3.5: Function of L-anap labeled Nav1.5 channels in HEK293T. (A) Representative TTX-
sensitive capacitance-normalized current traces of SCN5A(Q1475TAG) or wild-type SCN5A 
transfected in HEK293T in the presence or absence of 10 μM L-anap. All conditions were co-
transfected with L-anapRS-LeutRNACUA. Inset is the voltage protocol. (B) High-gain TTX-
sensitive capacitance-normalized traces of the SCN5A(Q1475TAG) +L-anap condition vs. wild-
type SCN5A using same voltage protocol as in (A). Arrow indicates late sodium current (INa,L). 
(C) Average peak current density (pA/pF) of all conditions. *p<0.05, Student’s t-test. (D) Time to 
half-complete inactivation (t1/2, ms) of the SCN5A(Q1475TAG) +L-anap condition vs. wild-type 
SCN5A. *p<0.05, Student’s t-test. (E) SSI of the SCN5A(Q1475TAG) +L-anap condition vs. 
wild-type SCN5A. Inset is the voltage protocol. 
 
Functional characterization of C-terminal EGFP labeled Nav1.5 
Reporter constructs of UAA-incorporation required labeling the Nav1.5 C-T with a FP. Does C-
terminally fused EGFP affect channel function? Preliminary data suggest that C-terminal EGFP 
fusion does not affect function (Figure 3.6) as much as L-anap incorporation in the III-IV linker 
(Figure 3.5). Figure 3.6 depicts functional characterization of SCN5A-EGFP in HEK293T by 
patch-clamp electrophysiology. Visually, representative TTX-sensitive current traces at high-gain 
indicate that neither construct resulted in significant late current (Figure 3.6A), but when the 
preliminary dataset was analyzed, wild-type +EGFP displayed significantly increased late current 
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compared to the EGFP-fused channels (Figure 3.6B). However, both levels of late current were 
under 0.2% of peak current, which manifests physiologically as wild-type. Peak current density 
was similar between SCN5A-EGFP and non-EGFP labeled channels (Figure 3.6C). Furthermore, 
inactivation kinetics measured by time to half-complete inactivation (t1/2) (Figure 3.6D) and 
channel availability measured by SSI protocols (Figure 3.6E) were not significantly different from 
wild-type channels co-expressed with EGFP.  
 
Figure 3.6: Electrophysiology of Nav1.5-EGFP expressed in HEK293T. (A) Representative high-
gain TTX-sensitive capacitance-normalized current traces of SCN5A-EGFP and wild-type 
SCN5A + EGFP expressed in HEK293T cells. Inset is the voltage protocol. *p<0.05, Student’s t-
test. (B) Late current measured as a percentage of peak current in SCN5A-EGFP and wild-type 
SCN5A + EGFP conditions. (C) Average peak current density (pA/pF) of SCN5A-EGFP and wild-
type SCN5A + EGFP conditions. p>0.05, Student’s t-test, ns. (D) Time to half-complete 
inactivation (t1/2, ms). p>0.05, Student’s t-test, ns.  (E) SSI curves of SCN5A-EGFP and wild-type 
SCN5A + EGFP. Inset is the voltage protocol.  
Characterization of DCT truncation effect on function of L-anap labeled Nav1.5 channels 
 
What happens to Nav1.5 function when the C-T is truncated, rather than labeled? The DCT 
truncated Nav1.5 mutant SCN5A(S1885TGA) has been previously characterized and corresponds 
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to the DCT truncated SCN5A(S1883TGA) construct used here (Figure 3.7A) [63]. DCT truncated 
Nav1.5(S1883TGA) channels showed no difference in expression and no significant change in the 
time to half-complete inactivation (t1/2) compared to wild-type (Figure 3.7B,C). However, for DCT 
truncated Nav1.5 channels, late current and a hyperpolarizing shift in SSI was observed previously 
and in this work (Figure 3.7A,D) [63].  
In cells expressing the single Nav1.5(Q1475L-anap) or the double mutant Nav1.5(Q1475L-
anap/S1883TGA), peak current density was significantly decreased compared to DCT truncated 
channels (Figure 3.7B). There may be a significant difference in peak current density between the 
Nav1.5(Q1475L-anap) and Nav1.5(Q1475L-anap/S1883TGA) conditions, but more recordings are 
needed for verification (Figure 3.7B). Both conditions, however, showed significantly increased 
peak current density compared to the negative control SCN5A(Q1475TAG) expressed in cells 
grown in the absence of L-anap (Figure 3.7B). 
Nav1.5 inactivation properties were also affected by combined L-anap labeling and DCT 
truncation. With Nav1.5(Q1475L-anap/S1883TGA), late current was observed (Figure 3.7A) and 
the time to half-complete inactivation (t1/2) was significantly increased compared to DCT truncated 
channels (Figure 3.7C). Steady-state inactivation and associated half-maximal voltages (mV) were 
measured for each construct: wild-type (-64.6 ±0.4), Q1475TAG + L-anap (-51.8 ±0.7), 
S1883TGA (-79.2 ±0.4), and Q1475TAG/S1883TGA + L-anap (-59.7 ±0.6). DCT truncation by 
itself caused a hyperpolarizing shift in SSI compared to wild-type (Figure 3.7D). L-anap labeling 
by itself caused a depolarizing shift in SSI compared to wild-type (Figure 3.7D). When the 
mutations were combined, DCT truncation shifted the Nav1.5(Q1475L-anap) SSI curve towards 
more hyperpolarized potentials, almost in line with the wild-type SSI curve (Figure 3.7D). These 
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data may suggest coordination of the III-IV linker and DCT in the modulation of Nav1.5 closed-
state inactivation and channel availability.  
 
 
Figure 3.7: Electrophysiology of DCT truncated and L-anap labeled Nav1.5 in HEK293T. (A) 
Schematic of full-length and DCT truncated constructs expressed in the presence or absence of L-
anap. All conditions were co-transfected with L-anapRS-LeutRNACUA. Underneath each 
schematic is the corresponding high-gain TTX-sensitive capacitance-normalized current trace. 
Arrow indicates late sodium current (INa,L). Inset is the voltage protocol. (B) Average peak current 
density (pA/pF) was measured for Q1475TAG and Q1475TAG/S1883TGA in +L-anap 
conditions; wild-type, S1883TGA, and Q1475TAG were measured without L-anap. *p<0.05 
single-factor ANOVA first to determine if all groups were significantly different, then Student’s 
t-test to compare pairs. (C) Time to half-complete inactivation (t1/2, ms) of constructs in (A) in the 
absence or presence of 10 μM L-anap. *p<0.05, as described in (B). (D) SSI of all constructs in 




Development of L-anap as local environment sensor in Nav1.5 inactivation gate 
An imaging assay was developed to detect L-anap fluorescence changes correlated with 
inactivation of Nav1.5 channels expressed in mammalian cells. Spectral imaging of L-anap was 
combined with K-depolarization to change channel state during imaging. Based on SSI curves of 
Nav1.5(Q1475L-anap) in Figure 3.7D, when the resting membrane potential (RMP) is set to a 
hyperpolarized potential with [K+]ext of 5 mM (Low K
+), channels at the membrane are expected 
to be in the resting, closed-available state. An increase to [K+]ext of 150 mM (High K
+) depolarizes 
the membrane, and thus, channels at the membrane are expected to open and quickly inactivate, 
resulting in open-inactivated channels at steady state. 
 Before employing the K-depolarization, however, fluorescence spectral imaging of L-anap 
labeled Nav1.5 channels expressed in HEK293T cells was established. There were two main 
reasons for this approach: (1) measuring spectra, as opposed to intensity changes, would account 
for differences in fluorescence intensity associated with varied expression of different L-anap 
incorporated constructs. (2) the output of L-anap environmental sensitivity is a shift in the 
fluorescence emission peak, and this unique property of L-anap could best be exploited during 
spectral imaging. Theoretically, shifts of a few nanometers are observable with optimal expression, 
laser excitation, image exposure, and high spectral resolution afforded by the confocal microscope 
spectral detector.  
A spectral image was acquired of cells expressing SCN5A(Q1475TAG), L-anapRS-
LeutRNACUA +10 μM L-anap (Figure 3.8A). L-anap fluorescence intensity was localized 
throughout the cell, but largely to intracellular structures (Figure 3.8A). Peak fluorescence 
intensity was 2x as bright in the purple circle compared with the other three ROIs (Figure 3.8A) 
Peak fluorescence emission ranged from 468 nm to 495 nm (Figure 3.8B). The average peak 
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emission of these four ROIs is 484 nm, which is in range of peak emissions measured from multiple 
cells in ensemble L-anap spectral experiments (Figure 3.9B). This experiment demonstrates that 
different cellular populations of L-anap can be distinguished by live-cell spectral imaging, 
however, comparison with negative control wild-type SCN5A +L-anap spectra is needed to 
distinguish the unincorporated L-anap population. These data depict one possible reason for the 
decreased sodium peak current density observed during electrophysiological characterization of 
Nav1.5(Q1475L-anap) (Figure 3.5C), compared to wild-type Nav1.5.  
 
Figure 3.8: Spectra of HEK293T expressing SCN5A(Q1475TAG) +L-anap. (A) HEK293T cells 
were transfected with SCN5A(Q1475TAG) and L-anapRS-tRNALeuCUA in the presence of 10 
μM L-anap. Spectral imaging (ex405, em410-600 nm) depicted localization of different L-anap 
populations within cells. (B) Peak-normalized spectra extracted from the ROIs drawn in (A). 
Maximum emission of each peak: purple ROI – 468 nm, orange ROI – 477 nm, light blue ROI – 
495 nm, pink ROI – 495 nm.  
Five different III-IV linker sites were tested for L-anap incorporation into SCN5A(TAG) 
expressed in HEK293T (Figure 3.9A). L-anap spectra associated with each site demonstrated 
unique emission peaks: Q1475TAG (centroid 480 nm), F1485TAG (centroid 484 nm), 
M1486TAG (centroid 488 nm), E1488TAG (centroid 482 nm), and E1489TAG (centroid 483 nm) 
(Figure 3.9B). Background L-anap in the presence of wild-type Nav1.5 was red-shifted with a peak 
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centroid of 489 nm (Figure 3.9B). Of the incorporated sites, Q1475L-anap was the most blue-
shifted and M1486L-anap was the most red-shifted. These data represent sensing of the local 
environment of L-anap in cells. These ROIs were drawn manually in a disc shape to attempt to 
isolate membrane-localized fluorescence. However, it cannot be ruled out that fluorescence from 
intracellular localized channels contributes to these spectra. These and other issues with 
interpreting the L-anap spectral data in cells are further discussed in Chapter 4, Limitations.  
 
Figure 3.9: L-anap at different sites in the III-IV linker senses local environmental change. (A) 
Schematic of the III-IV linker depicting the location of the five sites tested, Q1475, F1485, M1486, 
E1488, and E1489. F1485 and M1486 are a part of the ‘IFM’ motif, known as the inactivation 
particle. Adapted from PDB structure 5XSY [32] (B) L-anap spectra measured with L-anap at each 
of the five sites compared with wild-type SCN5A + 10 μM L-anap control. n = 12 cells for each 
condition, error bars are ±SEM.  
 
Next, the effect of DCT truncation on spectra of Nav1.5(Q1475L-anap) and 
Nav1.5(E1488L-anap) was measured in HEK293T (Figure 3.10A,B). There was no change in the 
L-anap spectra of DCT truncated channels. When Nav1.5(Q1475L-anap), Nav1.5(E1488L-anap), 
and wild-type +L-anap spectra are overlaid, the red-shifted pattern ([blue]Q1475  E1488  
wild-type[red]) reproduces that observed when L-anap was incorporated at each III-IV linker site 
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(Figure 3.9B). Current-clamp of non-expressing HEK293T revealed that the RMP of these cells is 
approximately -40 mV and increasing [K+]ext  depolarizes cells to 0 mV (Figure 3.10C). However, 
according to the SSI curves measured for Nav1.5(Q1475L-anap) channels (Figure 3.5C), at -40 
mV, most channels at the membrane are expected to be in the closed-inactivated state. In the 
closed-inactivated state, the DCT may not be playing an important role. Furthermore, if there is no 
change in membrane potential, a conformational change may not occur, or it may have been 
undetectable under these conditions. Therefore, a K-depolarization was used to modulate channel 
state and elicit spectral shifts associated with inactivation of L-anap labeled Nav1.5 channels at the 
plasma membrane.  
 
Figure 3.10: L-anap spectra did not shift with DCT truncation when cells were ~ -40 mV. (A) 
Spectra obtained from cells expressing Nav1.5(Q1475L-anap) (purple), Nav1.5(Q1475L-
anap/S1883TGA) (gold), or wild-type Nav1.5 + L-anap (black). Error bars are ±SEM. 12 L-anap 
positive cells were chosen for spectral analysis (B) Spectra obtained from cells expressing 
Nav1.5(E1488L-anap) (navy), Nav1.5(E1488L-anap/S1883TGA) (olive), or wild-type Nav1.5 + L-
anap (black). Error bars are ± SEM. 12 L-anap positive cells were chosen for spectral analysis. (C) 
Current clamp of non-expressing HEK293T with K-depolarization. Cell RMP was changed from 
~-40 mV at 5 mM [K+]ext to ~0mV at 150 mM [K
+]ext . 
K-depolarization has been used extensively for calcium imaging [241], and the approach 
in this work builds upon experiments imparting excitable properties to non-excitable cells by 
expression of inward-rectifier potassium channels (Kir) [242], [243]. Human Kir4.1 is one such 
channel responsible for setting RMP in neurons and muscle cells [244]. Kir4.1 is sensitive to [K
+]ext 
and thus, expression of these channels enables (1) establishment of the initial RMP at a 
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hyperpolarized potential such that VGSCs will be closed and available, and (2) depolarization of 
the RMP upon addition of increased [K+]ext to drive the transition between VGSC closed and open-
inactivated states [242], [243], [245]. A stable HEK293T cell line expressing GFP-Kir4.1 was 
obtained to modulate RMP during spectral imaging experiments (Figure 3.11A). A representative 
current-clamp trace demonstrates that transition from 5 mM [K+]ext (Low K
+) to 150 mM [K+]ext 
(High K+) changed the membrane potential from -76 mV to -5 mV (Figure 3.11B). The reversal 




Figure 3.11: Establishment of K-depolarization to control resting membrane potential (RMP). (A) 
Schematic of GFP-Kir4.1 stably expressed in HEK293T cells and corresponding fluorescence 
image. (B) Representative current-clamp trace of GFP-Kir4.1 HEK293T stable cells. Range in Vm 
is -80 mV to 0 mV with increasing [K+]ext  from 5 mM to 150 mM. (C) Reversal potential of GFP-
Kir4.1 cells can be changed from -80 mV in Low K
+ (5 mM [K+]ext) to ~0 mV in High K
+ (150 
mM [K+]ext). Inset is the voltage protocol. 
Expression of Nav1.5(L-anap) in the GFP-Kir4.1 HEK293T cell line resulted in composite 
L-anap-GFP spectra that were unmixed and fitted to measure shifting L-anap peaks. A 
representative false-color image depicts a mixed population of dual-labeled L-anap and GFP 
positive cells, as well as single-labeled L-anap or GFP positive cells (Figure 3.12B). Dual-labeled 
L-anap and GFP positive cells were manually chosen for spectral analysis. The spectrum from 
each cell was individually fitted and unmixed from background and GFP. Spectra were each 
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normalized to their respective ROI area, then to the sum of intensities under the peak. Resulting 
spectra were averaged and errors were calculated as ±SEM.  
Spectra of Nav1.5(Q1475L-anap) depict L-anap fluorescence shifts (shaded area) 
depending on [K+]ext and presence of the DCT (Figure 3.12C). At Low K
+, cell RMP is expected 
to be approximately -80 mV, a potential at which most channels at the membrane are expected to 
be closed (Figure 3.12A). At High K+, cell RMP is expected to be approximately 0 mV, a potential 
at which most channels at the membrane are expected to be open-inactivated (Figure 3.12A). 
Notably, K-depolarization caused no change in L-anap spectra of DCT truncated channels (Figure 
3.12C, Left, LowK+  HighK+). At Low K+, spectra of full-length Nav1.5(Q1475L-anap) 
displayed a slight red-shift outside of error, compared to DCT truncated channels (Figure 3.12C, 
Middle, Low K+). At High K+, spectra of full-length Nav1.5(Q1475L-anap) channels were red-
shifted compared to DCT truncated channels (Figure 3.12C, Right, High K+). In contrast, no shifts 
were observed in spectra measured from full-length or DCT truncated Nav1.5(E1488L-anap) 
channels (Figure 3.12D), nor from the negative control wild-type +L-anap (Figure 3.12E).  
If spectra represent L-anap labeled channels at the membrane, these data suggest the DCT 
participates in a conformational rearrangement of the III-IV linker that increases solvent exposure 
of Q1475L-anap in open-inactivated Nav1.5 channels. However, these spectra likely represent a 
combination of L-anap labeled channel populations – those localized at the plasma membrane and 
in intracellular structures – which complicates interpretation of these data (Chapter 4, Limitations). 
Despite limitations, a baseline L-anap spectral imaging K-depolarization assay in mammalian cells 
has been established. Further optimization of membrane expression of L-anap labeled Nav1.5 and 
spectral imaging of only the membrane, for instance, by TIRFM, would permit detection of III-IV 





Figure 3.12: L-anap spectra of Nav1.5(Q1475L-anap), Nav1.5(E1488L-anap), and their DCT 
truncated mutants with K-depolarization. (A) Schematic of K-depolarization in cells expressing 
GFP-Kir4.1 and Nav1.5(L-anap). Net flux of potassium is zero at both membrane potentials. 5 mM 
[K+]ext and 150 [K
+]int set the equilibrium potential at ~ -80 mV. Increase to 150 mM [K
+]ext sets 
the equilibrium potential at ~0 mV. (B) Representative false-color image of GFP-Kir4.1, Nav1.5(L-
anap) labeled HEK293T. (C) Spectra of Nav1.5(Q1475L-anap) with and without DCT truncation 
(S1883TGA) at Low K+ and High K+. Q1475TAGL-anap Low K+ n = 36, Q1475TAGL-
anap/S1883TGA Low K+ n = 21, Q1475L-anap High K+ n = 30, Q1475L-anap/S1883TGA High 
K+ n = 19, error bars ±SEM. (D) Spectra of Nav1.5(E1488L-anap) with and without DCT 
truncation (S1883TGA) at Low K+ and High K. E1488L-anap Low K+ n = 21, E1488L-
anap/S1883TGA LowK+ n = 20, E1488L-anap High K+ n = 59, E1488L-anap/S1883TGA High 
K+ n = 11, error bars ±SEM. (E) Control L-anap spectra measured in cells expressing wild-type 
Nav1.5 + 10 μM L-anap. Wild-type +L-anap Low K
+ n = 15, wild-type + L-anap High K+ n = 12, 
error bars ±SEM. 
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3.4 Summary of genetic encoding of a site-specific fluorescent sensor of human cardiac 
voltage-gated sodium channel inactivation  
Site-specific intracellular labeling of the Nav1.5 III-IV linker with the environmentally sensitive 
fluorescent UAA L-anap was achieved using aaRS-tRNA technology in mammalian cells. 
Function of the channels expressed in the presence of L-anap was characterized by patch-clamp 
electrophysiology, and little to no expression was observed in the absence of L-anap. While L-
anap incorporated in the III-IV linker altered the functional properties of Nav1.5 channel 
inactivation, these effects were within pathophysiological range. In addition, Nav1.5 function was 
minimally perturbed by C-terminal FP fusion in heterologous cells. 
Spectral imaging was used to measure L-anap emission in Nav1.5 in live mammalian cells. 
L-anap was largely localized to intracellular structures but electrophysiology and imaging suggest 
that a small population of channels reached the plasma membrane. L-anap sensed the local 
environment of the III-IV linker when incorporated at five different sites: Q1475TAG, F1485TAG, 
M1486TAG, E1488TAG and E1489TAG, and spectra were red-shifted in the absence of a target 
stop codon for incorporation. K-depolarization allowed sodium channel state at the plasma 
membrane to be changed from closed to open-inactivated during spectral imaging. A spectral shift 
in L-anap emission with K-depolarization represents III-IV linker conformational change in the 
open-inactivated state, which was absent when the DCT was truncated. These data suggest the 
DCT participates in conformational rearrangement of the III-IV linker associated with entry to the 
open-inactivated state. Together, Chapter 3 demonstrates site-specific intracellular labeling of 
human cardiac Nav1.5 in mammalian cells and spectral detection of fluorescent channel 
conformational change depending on channel state and presence of the DCT. 
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UAA aaRS-tRNA technology in mammalian cells can be used for intracellular fluorescent 
labeling, enabling biophysical studies of ion channels. A handful of proteins and UAAs were tested 
for successful UAA mutagenesis in mammalian cells: NbocK incorporated in EGFP and Nav1.5, 
BCNK incorporated in EGFR-EGFP, and L-anap incorporated in EGFP, H2B-mCherry and 
Nav1.5. Direct incorporation of the environmentally sensitive fluorescent UAA L-anap was 
reproducible and relatively easy compared to bioorthogonal fluorescent labeling via click 
chemistry. Bioorthogonal fluorescent labeling via click chemistry of extracellular BCNK-
incorporated EGFR was attempted and non-specific labeling with Tz-TAMRA was observed. 
Direct incorporation of environmentally sensitive fluorescent UAAs is powerful for sensing 
applications, but can be limited by low fluorescence signal. Bioorthogonal click-labeling allows 
for fluorophore modularity, which enables more advanced imaging, such as FRET and single-
molecule imaging, of ion channels. However, more work is needed to optimize this technique for 
labeling membrane proteins in mammalian cells. 
Towards development of a site-specific fluorescent sensor of Nav1.5 inactivation, the III-
IV linker was fluorescently labeled with L-anap. Single amino acid mutation of this region is 
sufficient to alter channel function, evidenced by LQT3 mutations and this work [2]. While 
channel function is altered by L-anap labeling of the III-IV linker, properties remained within 
pathophysiological range, and most closely mimicked those of a characterized LQT3 mutant 
channel F1473C [2]. Interestingly, C-terminal labeling of Nav1.5 with EGFP did not alter channel 
function as expected. Together, these methods facilitate experiments with LQT3 mutant channels 
that give insight on Nav1.5 structural dynamics in a pathological context. 
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Spectral imaging enabled characterization of L-anap labeled Nav1.5 expressed in 
mammalian cells. In ensemble spectral imaging experiments, L-anap spectra could be 
distinguished between conditions with the target amber stop codon for incorporation and those 
without. When Nav1.5(TAG) and L-anapRS-LeutRNACUA were expressed +L-anap, L-anap 
spectra were blue-shifted in comparison to wild-type Nav1.5 L-anapRS-LeutRNACUA expressed 
+L-anap. Unique L-anap spectra were observed with L-anap incorporated at five different sites in 
the III-IV linker, indicating sensing of the local environment. Then, the effect of the DCT was 
explored in relation to L-anap labeled III-IV linker. Functionally, DCT truncation caused a 
hyperpolarizing shift in the SSI of L-anap in the III-IV linker, suggesting that DCT truncation 
stabilizes closed-state inactivation of L-anap labeled channels.  
 A K-depolarization L-anap spectral imaging assay was developed to measure the effects of 
the DCT and channel state on conformational rearrangement of the III-IV linker. With expression 
of Kir4.1 and the K-depolarization, current-clamp demonstrated that cell RMP could be changed 
from -80 mV to 0mV. This provided the means to change Nav1.5 channels at the membrane to the 
open inactivated state, where III-IV linker C-T interactions are hypothesized to have a functional 
impact. In imaging experiments, L-anap spectra of full-length Nav1.5(Q1475L-anap) were red-
shifted at Low K+ and High K+, but this shift was not observed in DCT truncated channels. These 
data suggest the DCT may help promote entry into the open-inactivated state via participation in 
conformational rearrangement of the III-IV linker.  
Once optimized, the K-depolarization L-anap spectral assay could be a general assay for 
studying conformational dynamics of the Nav1.5 III-IV linker and regulators thereof in mammalian 
cells. It could provide insight on outstanding questions of VGSC regulation, for instance, by 
calcium, kinases (PKA, CAMKII, Fyn), and growth factors (FHF) [71]. Furthermore, the 
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development of such an assay can similarly be applied to other ion channels and membrane 
proteins to gain site-specific knowledge of their conformational dynamics in mammalian cells. 
4.2 Discussion 
Bioorthogonal fluorescent labeling of BCNK incorporated membrane proteins 
 
BCNK was incorporated into the EGFR(N128TAG)-EGFP reporter in mammalian cells to 
reproduce bioorthogonal fluorescent labeling of a click UAA (Figure 2.5) [191]. However, non-
specific labeling of Tz-TAMRA was observed. Based on the broad non-specific staining of cells, 
the primary issue was likely Tz-TAMRA labeling of unincorporated BCNK that could not be 
removed from the cell surface during wash steps. More experiments are needed to determine the 
optimal click UAA-Tz-dye pair. TCOK may be a better UAA to incorporate and label; this 
particular UAA has seen broader use than BCNK or NORK and is the most reactive of the trio 
[217], [246]. In-house synthesized Tz-dyes may be a better option moving forward because Tz 
reactivity can be finely tuned (private communication, Joseph Fox, Alexander Dieters). For 
example, Tz reactivity can be increased or decreased by addition of electron-withdrawing or 
electron-donating substituents, respectively [246]. Bioorthogonal chemistry in cells benefits from 
balancing reactivity and stability. Incorporation of a highly reactive UAA, such as TCOK, and 
fluorescent labeling with a moderately more reactive Tz than used herein would likely have 
resulted in more specific labeling [246]. 
In theory, bioorthogonal UAA labeling could be an alternative to direct fluorescent UAA 
incorporation since it enables labeling with brighter fluorophores more suitable for applications 
like single-molecule imaging or FRET, but more work is needed to prove this technology useful 
for biophysical studies of membrane proteins. While there are limitations on protein expression 
and background fluorescence associated with fluorescent UAA labeling of proteins in cells, genetic 
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encoding of UAAs offers advantages such as intracellular labeling, flexible single-site-specificity 
that cannot be achieved with FPs or peptide tags, and useful fluorescence properties like 
environmental sensitivity.  
UAA mutagenesis of Nav1.5 via aaRS-tRNA technology in mammalian cells 
 
UAA technology with model UAAs and model target proteins was reproduced, demonstrated by 
experiments incorporating NbocK into the EGFP(Y40TAG) fluorescent reporter in mammalian 
cells (Figure 2.3). This was a necessary proof-of-principle before testing whether the Nav1.5 III-
IV linker can be modified with NbocK. Seven sites in the Nav1.5 III-IV linker were permissible 
for NbocK incorporation – F1472, N1473, Q1475, K1478, D1483, I1484, and F1485 – reported 
by expression of EGFP fused to the Nav1.5 C-T (Figure 2.7). In the +NbocK conditions, a broad 
distribution of EGFP intensities from expressing cells was observed compared with cells grown in 
the absence of NbocK (Figure 2.7C).  
EGFP reporter expression is dependent on cell health, transfection efficiency, variable 
expression of the aaRS-tRNA pair, incorporation efficiency at the target amber stop codon, as well 
as maturation of the EGFP. Heterogeneity in the population of EGFP-expressing cells probably 
reflects the lifecycle of a multiplying culture over the two-day experiment during which cells are 
synthesizing and degrading UAA-incorporated and truncated proteins. The oldest cells could be 
the high-expressing EGFP-positive cells, having over-expressed reporter protein over many hours, 
whereas the younger cells have not had as much of a chance to incorporate UAA and express the 
reporter. Sorting of the low-expressing and high-expressing EGFP-positive cells and subsequent 
analysis of truncated and full-length Nav1.5-EGFP protein expression, as well as aaRS-tRNA 




L-anap labeling of Nav1.5 via aaRS-tRNA technology in mammalian cells 
 
Proof-of-principle experiments were reproduced by labeling of the intracellular H2B(V129TAG)-
mCherry reporter with the environmentally sensitive fluorescent UAA L-anap using an aaRS-
tRNA pair in mammalian cells (Figure 2.4). Then, the Nav1.5 III-IV linker was site-specifically 
labeled with L-anap. L-anap labeling of a fluorescent reporter SCN5A(Q1475TAG)-mCherry was 
imaged, demonstrating L-anap and mCherry fluorescence localization at the cell membrane and 
intracellular compartments (Figure 3.3). In these Nav1.5(Q1475L-anap)-mCherry imaging 
experiments, L-anap background fluorescence was observed and may result from non-specific 
labeling due to incomplete washout of unincorporated L-anap. Also, L-anap incorporation could 
potentially occur at non-target amber codons. In the absence of L-anap, cell auto-fluorescence was 
observed in the L-anap channel and very dim mCherry fluorescence was observed in the mCherry 
channel. Collected L-anap emission is in the blue visible light spectrum where cell auto-
fluorescence is expected due to fluorescence of natural amino acids and other biomolecules such 
as NADH and NADPH [226], [247]. mCherry background fluorescence may result from L-anap-
independent readthrough of the target stop codon or initiation of mCherry expression. It is notable 
that auto-fluorescence and background mCherry fluorescence signals were negligible compared to 
fluorescence signals when L-anap and its target site of incorporation were present.  
Electrophysiology of UAA-incorporated Nav1.5 in mammalian cells 
 
Patch-clamp electrophysiology revealed UAA-dependent sodium currents in cells expressing 
Nav1.5(Q1475TAG) +UAA, whereas little to no sodium currents were observed in the absence of 
UAAs (Figure 2.8, Figure 3.5). Electrophysiological characterization of SCN5A(Q1475TAG) 
+UAA demonstrated decreased peak current density, and for L-anap incorporation, imaging data 
suggest a large population of labeled channels are localized in intracellular compartments (Figure 
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3.3, Figure 3.8). Decreased peak current density could represent defective channel trafficking, 
lower channel expression, or decreased single-channel conductance. Single-channel functional 
characterization was not performed in this work and would clarify the possible effect of each UAA 
on single-channel conductance. Defective trafficking and lower channel expression, however, are 
expected to be primary causes of decreased peak current density. Lower expression of UAA-
labeled channels is expected due to competition with natural termination machinery at the site of 
incorporation. Defects in channel trafficking to the membrane are known to occur in the absence 
of β subunits, and could be compounded by an unknown trafficking effect associated with UAA-
incorporated channels [16]. 
Functionally, Nav1.5(Q1475TAG) channels expressed in the presence of NbocK 
demonstrated no change in inactivation kinetics (Figure 2.8D), but more recordings are needed to 
assess the effects of NbocK incorporation on late current and SSI. Similarly, EGFP labeling of the 
Nav1.5 C-T did not perturb function as expected (Figure 3.6). Other VGSC subtypes, such as 
Nav1.1, cannot be labeled with FPs because these constructs tend not to express (private 
communication, Lori Isom). However, in this work, Nav1.5 has been fused to a C-terminal FP and 
preliminary data suggest these channels’ expression and function are not significantly different 
from wild-type Nav1.5. In contrast, L-anap labeling of the III-IV linker impacted channel function 
(Figure 3.5). Recordings of Nav1.5(Q1475L-anap) revealed increased late current, lengthened time 
to half-complete inactivation (t1/2), and destabilized closed-state inactivation, represented by a 
depolarizing shift in SSI (Figure 3.5E). The increase in late current and depolarizing shift in SSI 
are similar to functional characteristics observed in LQT3 mutant F1473C channels [2]. While 
function of L-anap labeled channels is different than wild-type function, it is within 
pathophysiological range, and thus, L-anap labeled channels could serve as a model of LQT3 
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F1473C mutant channels [2]. Nonetheless, a wild-type fluorescently labeled channel would be 
ideal. More screening is needed to find sites that are minimally perturbed by L-anap incorporation.  
Site-specific sensing of Nav1.5 III-IV linker conformational change in mammalian cells 
 
Site-specific fluorescent labeling with L-anap combined with K-depolarization enabled direct 
monitoring of Nav1.5 III-IV linker conformational rearrangement in channels expressed in live 
mammalian cells. Towards developing this fluorescent sensor, L-anap was incorporated at multiple 
sites in the III-IV linker (Figure 3.9), but most of these mutants have not yet been characterized by 
patch-clamp electrophysiology, nor with truncation of the DCT. Further characterization of 
channels with L-anap at different sites in the III-IV linker, measuring spectral shifts and correlating 
them with changes in SSI would reveal how various sites in the III-IV linker participate in 
transitions between closed or closed-inactivated and open-inactivated states. Building on this basic 
experimental design, the effects of the DCT and putative functional channel regulators on 
transition to inactivated states can be evaluated with L-anap at different III-IV linker sites. 
 The DCT likely participates in conformational rearrangement of the III-IV linker when 
channels assume the open-inactivated state (Figure 3.12). Evidence for this is the red-shift of L-
anap spectra at Q1475 in full-length channels, compared to DCT truncated channels, at high [K+]ext  
(~0 mV). When channels are open-inactivated and the C-T is intact, a conformational 
rearrangement of the III-IV linker could result in cytosolic exposure of Q1475, producing red-
shifted spectra. The observations that (1) L-anap spectra are unshifted in DCT truncated channels 
with K-depolarization (Figure 3.12C), and (2) DCT truncation stabilizes closed-state inactivation 
of L-anap labeled channels (Figure 3.7D) suggest the absence of the DCT may prevent entry into 






The imaging and electrophysiology data indicate that a large population of L-anap labeled sodium 
channels are localized to intracellular structures. Sodium channel reserves are maintained in the 
ER and β subunits play a key role in trafficking channels to the plasma membrane [16], [248]. 
Over-expression also tends to promote ER localization artifacts [249]. Co-localization experiments 
would clarify the localization of L-anap labeled channels within cells. Imaging of L-anap labeled 
sodium channels, ER co-markers, such as Sec61β, and plasma membrane co-markers, such as 
cadherins, would depict the channel population retained in the ER and the population that reaches 
the membrane [250], [251]. Spectral imaging analysis for the K-depolarization collects L-anap 
signal associated with the entire cell, channels at the plasma membrane and intracellular structures 
included. An obvious next step is to perform TIRFM combined with spectral detection, which 
would enable targeted spectral measurements of the plasma membrane-localized population of L-
anap labeled sodium channels.  
 Since many channels are not at the plasma membrane, there is spectral information derived 
from channels not subject to voltage control imposed by Kir4.1 expression and the K-
depolarization. I expect these channels would behave similarly to those tested in the imaging 
experiments without Kir4.1 co-expression, and thus be in closed-inactivated states (Figure 3.10), 
but this is difficult to predict. The shifts measured in the K-depolarization assay may reflect 
differences in trafficking of full-length channels versus DCT truncated channels associated with 
changing [K+]ext, in addition to conformational change. More experiments are needed to assess the 
confounding effects of sodium channel trafficking on the spectral readout of this assay. 
Electrophysiology data demonstrate that the DCT truncation stabilizes the closed-
inactivated state of L-anap labeled channels, represented by a hyperpolarizing shift in SSI (Figure 
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3.7D). With High K+ or in closed-inactivated channels stuck in traffic, perhaps DCT truncated 
channels absorbed in the closed-inactivated state could not change to a state that involves 
rearrangement of the III-IV linker. Electrophysiology data demonstrate that the closed-inactivated 
state of full-length L-anap labeled channels is destabilized (depolarizing shift in SSI, Figure 3.7D). 
Therefore, with High K+ or in closed-inactivated channels stuck in traffic, full-length L-anap 
labeled channels may be more prone to transition to an available state from which they can access 
the open-inactivated state, eliciting the observed red-shift. Therefore, more marked shifts may be 
possible to observe with increased plasma membrane expression of L-anap labeled channels, 
where channel populations could be set more homogeneously in the closed – not closed-inactivated 
– or open-inactivated states.  
 Another potential limitation is the estimate of RMP of cells during the K-depolarization 
assay, which determines how channel states are assigned at Low K+ and High K+. The intracellular 
potassium concentration of HEK cells in this experiment may not be as high as the 150 mM 
estimated, although most mammalian cells have [K+]int of ~140 mM [252]. Assuming potassium 
dominates the RMP [8], by the Nernst Equation [252], if [K+]int of HEK293T cells expressing 
GFP-Kir4.1 is as low as 100 mM, the RMP is depolarized to ~ -70 mV, which is depolarized enough 
to have a population of closed-inactivated sodium channels at the membrane. These issues present 
another complication to interpreting the K-depolarization imaging data because channels at the 
membrane, even at Low K+, may be in a mixed population of closed and closed-inactivated states. 
If a population of channels at the membrane are in closed-inactivated states initially, they are not 
able to enter the open-inactivated state at High K+, which may also explain a smaller shift or lack 
of shift with K-depolarization. 
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In light of eukaryotic VGSC structures… 
The recent cryo-EM structures of eukaryotic VGSCs, Periplaneta americana NavPaS and 
Electrophorus electricus Nav1.4, place in context structural rearrangement of the L-anap labeled 
III-IV linker upon transition to inactivated states [24], [32]. The entire III-IV linker interacts with 
the proximal structured part of the C-T in the resolved structure of NavPaS [24]. In NavPaS, 
“Q1475” is located on the downstream end of the DIII:S6 α helix and “E1488” is the second site 
downstream from the inactivation particle IFM motif, located in the more flexible non-helical 
portion of the III-IV linker [24]. This structure suggests that “Q1475”L-anap is close to the 
membrane, which may explain why L-anap at that site is blue-shifted compared to L-anap at more 
downstream sites like E1488 (Figure 3.9B) [24].  
In the Electrophorus electricus Nav1.4 channel structure, the C-T was invisible at this 
higher resolution, so no III-IV linker-C-T interaction was observed [32]. In comparison with 
NavPaS, the III-IV linker is positioned closer to the membrane and in parallel to the DIV:S4-S5 
linker [32]. The LFM motif, analogous to the inactivation particle IFM in human channels, is 
plugged into a corner of the underside of the pore and does not directly block the intracellular gate 
– which is open in this structure – along the permeation path [32]. The authors suggest this data 
may indicate the intracellular gate within the pore is closed through allosteric motion of the III-IV 
linker, rather than directly blocking the pore. However, another hypothesis could be that the 
unresolved C-T forms the lid that blocks the permeation path and the III-IV linker binds and 
stabilizes the C-T in its lid conformation, thus blocking an open permeation path. More structural 





Applications of L-anap labeled Nav1.5 
 
Nav1.5 voltage sensor movement 
 
The L-anap spectral imaging K-depolarization assay can be applied to study other regions of the 
channel. For instance, L-anap labeling of each domains’ voltage sensor S4, e.g. DI(L-anap)-DII-
DIII-DIV, DI-DII(L-anap)-DIII-DIV, etc., would permit separate monitoring of each voltage 
sensor movement upon transition to inactivated states in mammalian cells. Based on VCF 
experiments in X. laevis oocytes, voltage sensor movement is expected to elicit a more marked 
shift in L-anap fluorescence due to the dramatic conformational change of these channel regions 
[253]. Since there is a great deal of data on VGSC voltage sensor movement obtained from VCF 
in X. laevis oocytes [253]–[258], this experiment would enable comparison between these 
heterologous systems and, therefore, provide a more detailed picture of Nav1.5 voltage sensor 
dynamics. A patch-clamp mammalian cell spectral imaging setup would facilitate such an 
experiment, circumventing the need for K-depolarization.  
L-anap VCF in mammalian cells 
 
L-anap VCF is already gaining traction as a means for studying ion channel conformational 
dynamics in X. laevis oocytes [165]. A combined patch-clamp electrophysiology TIRFM setup 
would be ideal for L-anap VCF in mammalian cells. With sufficient fluorescence signal-to-noise, 
this type of experiment would permit dynamic measurements of L-anap fluorescence intensity 
changes correlated with channel function. Similarly, L-anap spectral shifts, if a spectral detector is 
included in the setup, would be a more sensitive measure of conformational rearrangements 
associated with channel function. Furthermore, if a L-anap-FP FRET pair were to be established 
in this system, FRET could be detected while patching, enabling direct measurement of voltage-
dependent intramolecular interactions in Nav1.5. 
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Calcium regulation of Nav1.5 
 
In Chapter 1, controversy surrounding calcium regulation of VGSCs was introduced. The key 
question is: does calcium regulate Nav1.5, and if so, how? Photocaged calcium compounds were 
developed to control and measure intracellular calcium concentration during patch-clamp 
experiments and have been useful in teasing apart calcium regulation of VGICs [82]. Experiments 
combining electrophysiology and imaging with activation of photo-caged calcium compounds 
shed light on calcium regulation of Nav1.5. In HEK293T, photo-uncaging increased intracellular 
calcium concentration to 10 μM (Figure 4.1, unpublished data, private communication M. Ben 
Johny). While full-length wild-type Nav1.5 function remained unaffected, calcium-dependent 
inactivation (CDI) was observed in L1921* channels, and CDI was abrogated by co-expression 
with dominant negative CaM1234. Thus, calcium regulation observed in L1921* truncated channels 
was mediated by CaM.  
 
Figure 4.1: Truncation of the distal C-terminus (L1921*) unmasks calcium-dependent inactivation 
of Nav1.5 mediated by CaM in HEK293T (unpublished data, M. Ben Johny). (Left) Full-length 
Nav1.5 is not subject to calcium-dependent inactivation upon increase of intracellular calcium. 
(Middle) L1921* DCT truncated Nav1.5 exhibits CDI upon increase of intracellular calcium. 
(Right) In the presence of dominant negative CaM1234, CDI of L1921* DCT truncated channels 
was abolished. 
First, these data highlight the unique utility of combined fluorescence and 
electrophysiology experiments to address questions of ion channel regulation. Second, they 
provide context for the DCT truncation mutant S1883TGA data presented herein. The difference 
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between truncation mutants L1921* and S1883TGA is that L1921* contains the IQ domain, a 
canonical CaM binding site [82]. Data from electrophysiology experiments and the L-anap spectral 
imaging K-depolarization assay herein indicate cooperation between the III-IV linker and the 
region downstream of S1883 in regulating Nav1.5 inactivation. No spectral shift was observed in 
Nav1.5(Q1475L-anap/S1883TGA) channels with K-depolarization (Figure 3.12). An exciting 
application of an optimized L-anap spectral K-depolarization assay would be to ask whether the 
presence of the IQ domain in the DCT truncated Nav1.5 mutant rescues conformational 
rearrangement of the III-IV linker, represented by a spectral shift with increased intracellular 
calcium. If it does, does the presence of dominant negative CaM1234 prevent that rescue? Also, 
what is the effect of increased intracellular calcium and the presence of dominant negative CaM1234 
on the spectral shift observed in full-length channels? Such experiments could provide direct 
evidence of the interplay between the III-IV linker, DCT, and calcium/CaM and their potential 
regulatory effects on Nav1.5 inactivation in live mammalian cells. 
FRET 
 
FRET between L-anap in the III-IV linker and the FP labeled C-T would directly measure their 
interaction in channels expressed in mammalian cells. When excited at 365 nm, L-anap has been 
demonstrated as a FRET donor to EGFP in purified proteins [233]. Transitioning from FRET with 
purified proteins to FRET in cells, however, is technically challenging. This is especially true given 
the relatively low L-anap fluorescence signal in cells and the mismatch in fluorescence intensities 
between L-anap and FPs (Figure 3.3, Figure 3.8). However, spectral FRET may be able to capture 
more subtle energy transfer between the L-anap and FP labeled Nav1.5. The modified linear 
unmixing analytical tool developed in this work enables spectral characterization of L-anap 
intensity and emission shifts in cells, and, with further modification, provides the analytical tool 
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necessary for live-cell spectral FRET experiments. Thus, a sought after next step is to determine 
the optimal L-anap labeling sites and conditions to measure Nav1.5 intramolecular interactions in 
live mammalian cells by FRET. Testing a variety of L-anap labeled sites would allow calculation 
of FRET efficiencies between different interacting sites on the III-IV linker and C-T. This adds 
much needed complexity to the images gained from structural studies, which often only capture 
one state of the protein in an isolated environment. Although structural characterization is 
necessary for visualizing the minute details of Nav1.5 structure, live-cell FRET measurements 
would provide a dynamic picture of interactions involved in VGSC inactivation.   
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All reagents were purchased commercially. Nε-boc-L-lysine (Nε-tert-butyloxycarbonyl-L-lysine) 
(Chem-Impex International) was dissolved in 0.1 M NaOH and acidified with HCl to pH 7.4 to 
make a stock solution of 167 mM. A 1.7 mM stock solution of L-anap (3-((6-acetylnaphthalen-2-
yl)amino)-2-aminopropanoic acid) (AsisChem) was made in DMSO. Absorbance spectra were 
obtained using a Tecan spectrometer and the peak at 355 nm of 40x diluted L-anap was 0.75. By 
Lambert-Beer’s Law [86], using extinction coefficient of 17,500 and path length of 1 cm, stock 
solution concentration was calculated to be 1.7 mM. A 0.5 M stock solution of exo BCN-L-lysine 
(bicyclo[6.1.0]nonyne-L-lysine) (SiChem) was made by dissolving BCNK in DMSO, then adding 
formic acid (1/3 amount of DMSO) to aid dissolution. A 1 mM stock solution of tetrazine-5-
TAMRA (3-(p-Benzylamino)-1,2,4,5-tetrazine-5-Carboxytetramethylrhodamine) (Jena 
Biosciences) was made in DMSO. TTX (Abcam) was dissolved in double-distilled H2O (ddH2O) 
at a stock concentration of 5 mM. On each day of patch-clamp electrophysiology experiments, a 
fresh 50 μM TTX solution was made in ddH2O from 5 mM stock solution. Reagents were aliquoted 
and stored at -20°C. Chemicals for physiological solutions were purchased from Sigma-Aldrich 




HEK293T and tsA-201 are two names for the same cell line [259]. HEK293T cells were obtained 
from frozen stocks available in the Cornish or Kass Labs. The stable GFP-Kir4.1 HEK293T cell 
line was a gift from Christopher Ahern. 
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5.2 Molecular biology 
QuikChange site-directed mutagenesis (Stratagene) was performed according to the 
manufacturer’s instructions with modification as needed. Primer melting temperatures (Tm) were 
calculated using formula: Tm = 81.5 +0.41(%GC) – 675/N - % mismatch. An optimized PCR 
protocol was used for site-directed mutagenesis of pcDNA3-SCN5A hh1c (11,752 basepairs):  
Site-Directed Mutagenesis 50 μL Reaction Final Concentration PCR Program 
10x PfuUltra Buffer 5 μL 1x 95C/:30 
10 mM dNTPs 1 μL 200 μM 95C/:30 
10 μM Forward Primer 2.5 μL 0.5 μM 55C/1:00 
10 μM Reverse Primer 2.5 μL 0.5 μM 68C/12:00 
10 ng/μL Template DNA 1 μL 0.2 ng/μL Steps 2-4, repeat 18x 
2.5 U/μL Pfu Ultra DNA 
Polymerase 
1 μL 0.05 U/μL 4C/hold 
Nuclease-free water To 50 μL   
Gibson Assembly (NEB) was performed according to the manufacturer’s instructions with 
modifications as needed. Primer for assembling each construct were designed using the NEBuilder 
Assembly Tool. PCRs of inserts for Gibson Assembly were performed with Q5 High-Fidelity 
DNA Polymerase (NEB) or Vent High-Fidelity DNA Polymerase (NEB). According to 
manufacturer’s instructions, Gibson Assembly MasterMix (NEB) was added to PCR amplified 
vector and inserts. Generally, 60 ng vector and a 1:1 or 1:3 molar ratio of inserts was added when 
assembling at least three fragments (vector + two inserts), depending on fragment size. If insert 
and vector were of a similar size, ratio was 1:1. Inserts were amplified by either Q5 High-Fidelity 
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DNA Polymerase or Vent High-Fidelity DNA Polymerase. Vectors>5 kb were amplified using an 
optimized Q5 PCR protocol.  
Q5 PCR Protocol 50 μL Reaction Final Concentration PCR Program 
5x Q5 Buffer 10 μL 1x 98C/:30 
10 mM dNTPs 1 μL 200 μM 98C/:10 
10 μM Forward Primer 2.5 μL 0.5 μM 50-72C/:30 
10 μM Reverse Primer 2.5 μL 0.5 μM 72C/:30/kb 
10 ng/μL Template DNA 1 μL 0.2 ng/μL Steps 2-4, repeat 30x 
2U/μL Q5 High-Fidelity 
DNA Polymerase 
0.5 μL 0.02 U/μL 72C/2:00 
4C/hold 
Nuclease-Free water To 50 μL   
 
Vent PCR Protocol 50 μL Reaction Final Concentration PCR Program 
10x ThermoPol Buffer 5 μL 1x 95C/2:00 
95C/:30 
10 mM dNTPs 0.5 μL 100 μM 50C-72C/:30 
100 μM Forward Primer 0.5 μL 1 μM 72C/1 min/kb 
100 μM Reverse Primer 0.5 μL 1 μM Steps 2-4, repeat 25x 
10 ng/μL Template DNA 2.0 μL 0.4 ng/μL 72C/5:00 
2U/μL Vent DNA 
Polymerase 
0.5 μL 0.02 U/μL 4C/hold 
 
Nuclease-Free Water To 50 μL   
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5.3 Mammalian tissue culture and transfection 
HEK293T cells were grown in a medium containing Minimum Essential Medium (MEM) (Gibco) 
or Dulbecco’s Modified Eagle Medium (DMEM) containing 4.5 g/L glucose, L-glutamine, and 
sodium pyruvate (Corning 10-013-CM), 10% Fetal Bovine Serum (FBS), 1% Penicillin-
Streptomycin, and 2 mM GlutaMAX (Gibco) supplement at 37ºC in a humidified atmosphere of 
5% CO2. Transfections of all cell lines for western blot, flow cytometry, and live-cell imaging (6-
well tissue-culture-treated plates for western blot and flow cytometry, LabTek 8-well chambered 
coverglass tissue-culture-treated plates for imaging) were performed using Xtremegene HP 
(Roche) or Lipofectamine 2000 (Invitrogen) according to manufacturer’s instructions. A typical 
imaging experiment involved transfection of 1 μg total DNA including 0.6 μg SCN5A(TAG), 
H2B(TAG), or EGFR(TAG) reporter constructs and 0.4 μg aaRS-tRNA (1.5:1 target protein to 
aaRS-tRNA mass ratio). Plasmids were co-transfected with reagent (3 μL reagent to 1 μg DNA) 
in Opti-MEM (Gibco). In +L-anap conditions, L-anap was added to the well at a final 
concentration of 10 μM ~30 minutes prior to adding transfection reaction. This recipe was scaled 
up to 2 μg total DNA for electrophysiology experiments, transfected in T25 flasks then split 24 
hours later and seeded into 35 mm plates. EGFP or EGFP(Y40TAG) was co-transfected as a 
marker of cells to patch as needed (1:1 with SCN5A(TAG)). GFP-Kir4.1 HEK293T were cultured 
in DMEM (Gibco), 10% FBS, 1% Penicillin-Streptomycin, 2 mM GlutaMAX, and Zeocin (Gibco) 
at 37ºC in a humidified atmosphere of 5% CO2. 
5.4 Western blot 
HEK293T cells were seeded at 3x105 cells/well in a 6-well tissue-culture-treated plate, transfected 
according to manufacturer’s instructions. 1.2 μg of DNA encoding SCN5A(Q1475TAG)-EGFP, 
SCN5A-EGFP, EGFP(Y40TAG), or EGFP was co-transfected with 0.8 μg of L-anapRS-
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LeutRNACUA with Xtremegene (Roche) at a ratio of 3:1 in Opti-MEM (Gibco) supplemented with 
2 mM GlutaMAX. 10 μM L-anap was added to the media ~30 minutes prior to adding transfection 
reaction. Transfected cells were cultured at 37°C, 5% CO2 36-48 hours before harvesting and lysis. 
Prior to lysis, cells were washed once with tris-buffered saline (TBS), then lysed with Cell Lysis 
Buffer (Cell Signaling) with 1:100 proteasome inhibitor complex on ice for 5 minutes. Lysis buffer 
contains (mM) 20 Tris-HCl (pH 7.5), 150 NaCl, 1 Na2EDTA, 1 EGTA, 1% Triton, 2.5 sodium 
pyrophosphate, 1 β-glycerophosphate, 1 Na3VO4, 1 μg/mL leupeptin. Cells were scraped and re-
suspended in lysis buffer and incubated at 4°C for 30 minutes. Samples were centrifuged 10 
minutes at 12,000xg then heated (55°C). Samples were loaded onto a 5% and 10% SDS-PAGE 
(sodium dodecyl sulfate polyacrylamide gel electrophoresis) gel and electrophoresed for 45 
minutes at 10 mA/gel, then 90 minutes at 20 mA/gel. Protein gels were wet-transferred onto 
polyvinylidene difluoride (PVDF) membranes overnight at 4°C (15 V). The membranes were 
washed briefly with TBS then blocked with 5% w/v skim milk in 1x TBS with Tween 20 (TBS-
T) for 30 minutes at room temperature. Membranes were then incubated with 1/8000 primary 
antibody (rabbit polyclonal anti-GFP) in (TBS-T) for 1 hour at room temperature. Membranes 
were washed 3x10 minutes at room temperature in TBS-T and incubated with secondary antibody 
(anti-rabbit horseradish peroxidase) 30 minutes at room temperature. Membranes were washed 
2x10 minutes at room temperature with TBS-T, then 1x10 minutes at room temperature with TBS, 
and developed using the ECL Western Blot Detection Reagents (Bio-Rad). The image was taken 
by exposing light sensitive films at 30 seconds, 1 minute, 2 minutes, 3 minutes, and 5 minutes to 
a developer (Kodak) in a dark room. Membranes were stripped, stained with anti-β-tubulin, and 
imaged as above.   
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5.5 Flow cytometry 
Flow cytometry was performed on a BD AccuriC6 flow cytometer or a BD LSRII. 12-24 hours 
prior to transfection, HEK293T cells were seeded at a density of 2-4x104 cells per well in a 6-well 
tissue-culture-treated plate. The next day, each well was transfected with 2 μg DNA + 6 μL of 
XtremeGene HP reagent in Opti-MEM to a total of 200 μL. For unnatural amino acid incorporation 
experiments, NbocK was added to the well at a final concentration of 1 mM ~30 minutes prior to 
adding transfection reaction. The optimal ratio of aaRS-tRNA and target POI plasmids was 
experimentally determined (by EGFP(Y40TAG) reporter) to be 1:1.5, and this ratio was used for 
all future experiments. Transfections were set up according to manufacturer’s instructions. 
Transfected cells were incubated at 37°C, 5% CO2 for 18-48 hours. Optimal expression of reporter 
protein in the presence of UAA occurred at ~36 hours post-transfection. This timepoint was 
determined experimentally using NbocK-dependent expression of the EGFP(Y40TAG) reporter. 
In preparation for flow cytometry, cells were gently washed with 1 mL phosphate-buffered 
solution (PBS) per well then trypsinized with 500 μL Trypsin-EDTA for 3 minutes at 37°C, 5% 
CO2. Trypsin-EDTA was quenched with 500 μL media and cells were re-suspended and 
transferred to 1.5 mL eppendorf tubes. Cells were pelleted at 3000 rpm for 3 minutes in a benchtop 
centrifuge. Supernatent was removed, and cells were re-suspended in 500 μL Hanks’ Balanced 
Salt Solution (Gibco). Then, the cell suspension was filtered through 40 μm cell strainers (Corning 
Falcon) into fresh eppendorf tubes to remove any aggregates. These samples were loaded onto the 
flow cytometer. Data was analyzed using FlowJo V10. 
5.6 Whole-cell patch-clamp electrophysiology 




Electrophysiological recordings of sodium channels expressed in HEK293T were carried out in a 
whole-cell patch clamp configuration using physiological solutions. Pipette resistances ranged 
from 1.5-4 MOhm. The INa internal solution contained (mM) 50 aspartic acid, 60 CsCl, 5 Na2-
ATP, 11 EGTA, 10 HEPES, 1 CaCl2 and 1 MgCl2, with pH 7.4 adjusted with CsOH. The INa 
external solution contained (mM) 130 NaCl, 2 CaCl2, 5 CsCl, 1.2 MgCl2, 10 HEPES, 5 glucose, 
with pH 7.4 adjusted with CsOH. Whole cell sodium currents were recorded under voltage-clamp 
conditions. A voltage step protocol was employed, holding at -100 mV, step depolarization to -20 
mV for 200 ms, then back to holding. Cells were pulsed at a frequency of 0.1 Hz. SSI voltage 
protocol was as follows: holding at -100 mV or -90 mV, step to the conditioning pulse for 500 ms, 
depolarization to -10 mV for 20 ms, return to holding. Conditioning pulses ranged from -130 mV 
to -20 mV. Late sodium current was measured as TTX-sensitive current 200 ms after 
depolarization to -20 mV. Percent late current was measured as the average current between 195 
mV and 200 mV divided by the peak current. Data was collected using Axopatch 200B amplifiers 
(Axon Instruments), Digidata 1440A model, and recorded with pClamp8 or 10 or 10.5 (Molecular 
Devices). Capacity current and series resistance compensation were carried out using analog 
techniques according to the amplifier manufacturer (Axon Instruments). All measurements were 
obtained at room temperature (25°C). Statistical significance was determined using single-factor 
ANOVA when comparing multiple groups and Student’s t-test assuming equal or unequal 
variances based on a prior F-test of variance. p<0.05 was considered statistically significant.   
Potassium channel electrophysiology 
 
Electrophysiological recordings of GFP-Kir4.1 HEK293T were recorded under voltage-clamp or 
current-clamp conditions. Internal solution contained (mM) 150 KCl, 3 MgCl2, 5 EGTA, 10 
HEPES, with pH 7.4 adjusted with KOH. Intracellular solution was specifically made without ATP 
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because Kir channels can be ATP-sensitive (private communication, Michael Bohnen). 
Extracellular solution contained (mM) 150 NaCl, 5 KCl, 1 MgCl2, 1.8 CaCl2, 10 HEPES, with pH 
7.4 adjusted with NaOH. Changes in membrane potential were recorded over time once patch 
stability and Kir4.1 channel expression were confirmed by applying a voltage ramp protocol: cells 
were held at -80 mV and a 500 ms voltage ramp was applied once every 3 seconds, with voltage 
increasing linearly from -120 mV to +60 mV, then returned to holding. Using pClamp software, a 
50X data reduction of recordings was performed for data transfer compatibility to Microsoft Excel 
and Origin (Microcal Software) software. All measurements were obtained at room temperature 
(25°C). Where appropriate, as in comparing reversal potentials between Low K+ and High K+, 
statistical significance was determined using Student’s t-test assuming equal or unequal variances 
based on a prior F-test of variance. p<0.05 was considered statistically significant.   
5.7 Live-cell imaging 
BCNK incorporation and Tz-TAMRA labeling 
HEK293T were plated at a density of 10,000-20,000 cells per well in LabTek 8-well chambered 
coverglass tissue-culture-treated plates (Nunc, 1.5 borosilicate) 12-24 hours before transfection. 
Transfections were performed as described previously. BCNK was added to the well at a final 
concentration of 0.25 mM ~30 minutes prior to adding transfection reaction. 24-36 hours post-
transfection, 0.4 mM Tz-TAMRA was added for 60 minutes. The media was exchanged three 
times, then live-cell imaging solution (Molecular Probes) was added and exchanged once. Cells 
were imaged on a Zeiss LSM 700 confocal microscope. EGFP was excited at 488 nm and 




L-anap labeling and spectral imaging 
HEK293T were plated at a density of 10,000-20,000 cells per well in LabTek 8-well chambered 
coverglass tissue-culture-treated plates (Nunc, 1.5 borosilicate) 12-24 hours before transfection. 
Transfections were performed as described previously. Fluorescence microscopy was performed 
on a Zeiss LSM 700 confocal microscope. Fluorescence microscopy and spectral imaging were 
performed on a Zeiss LSM 880 or Nikon A1RMP confocal microscope with spectral detector. L-
anap was excited at 405 nm and spectral emission collected from 410-600 nm in 6 nm intensity 
bins (Nikon) or 10 nm intensity bins (Zeiss). 405 nm excitation laser power ranged from 5% 
(Nikon) to 11% (Zeiss). All ensemble spectral experiments were performed using images taken 
at 20x magnification. Spectra were converted to TIFF stacks and imported into Fiji (ImageJ) 
where ROIs were chosen manually. Intensity over wavelength was measured for each ROI. 
Spectra were normalized to ROI area. Each ROI’s area-normalized spectrum was subtracted by a 
background area-normalized spectrum measured nearby the original ROI which did not contain a 
visible cell. These spectra were normalized to the sum of the intensities under the peak. 
Resulting normalized spectra were averaged and errors were determined as ±SEM. Peak 
centroids of each averaged spectrum were calculated as:  




L-anap spectral imaging with K-depolarization 
 
For spectral experiments on the Nikon, cells were maintained at 37°C in a 5% CO2 humidified 
atmosphere on the microscope with a stage-top incubator in live-cell imaging solution 
(MolecularProbes) or electrophysiological solutions. Live-cell imaging solution contained (mM) 
140 NaCl, 2.5 KCl, 1.8 CaCl2, 1.0 MgCl2, 20 HEPES, with pH 7.4. In K-depolarization 
experiments, Low K+ external solution contained (mM) 150 NaCl, 5 KCl, 1 MgCl2, 1.8 CaCl2, 10 
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HEPES, with pH 7.4 adjusted with NaOH. High K+ external solution contained (mM) 150 KCl, 5 
NaCl, 1 MgCl2, 1.8 CaCl2, 10 HEPES, with pH 7.4 adjusted with KOH. During imaging, cells 
were maintained in Low K+ external solution. Buffer exchange was performed either by changing 
buffer within one well (Figure 5.1, same well), which had the undesired tendency of removing 
cells in the field of view, or changing buffer in a second well of the same condition, then imaging 
(Figure 5.1, different well). Control wild-type +L-anap background spectra remained unshifted 
when comparing the two methods of K-depolarization. 
 
Figure 5.1: Wild-type L-anap spectra between two methods of K-depolarization. Low K+ same 
well n = 17, High K+ same well n = 17, Low K+ different well n = 15, High K+ different well n = 
12 
5.8 K-depolarization imaging data analysis 
Model spectra for linear unmixing of K-depolarization experimental spectra 
 
In K-depolarization experiments, composite L-anap and GFP spectra were fitted and unmixed 
using a modified linear unmixing algorithm in MATLAB (Mathworks). Two spectral components 
are modeled to fit and unmix experimental spectra: (1) L-anap, and (2) GFP. This is how the model 




The model L-anap spectrum was extracted from L-anap-only control HEK293T expressing 
SCN5A(Q1475L-anap) and fit as the linear combination of two gaussians to obtain a smooth 
spectrum. Determination of the central wavelength and shape of extremely blue-shifted L-anap 
peaks was complicated by the presence of laser light background at 405 nm and a notch filter, 
which is meant to filter out the laser light. A model spectrum of the peak 405 nm laser light 
background was determined by measuring spectra from ROIs drawn where there are no visible 
cells. When a substantial part of the peak falls within the range of the notch filter, a model filter 
function is included to better fit the notch-induced distortions in peak shape when blue-shifting the 
model L-anap spectrum.  
(2) GFP 
The GFP model spectrum was extracted from GFP-only control GFP-Kir4.1 co-transfected with 
SCN5A(Q1475TAG) and L-anapRS-LeutRNACUA in the absence of L-anap. First, the GFP model 
spectrum was laser-subtracted using the model spectrum obtained in (1). The best GFP fit was a 
linear combination of two log-normal distributions [260]. A long tail on the short-wavelength side 
of the GFP spectrum was observed in many, but not all, cases and needed to be modeled by an 
additional gaussian fit. Therefore, a second fitting test was performed where the best fit was 
determined between functions including or excluding the short-wavelength tail. 
Linear unmixing 
 
Once the model spectra were obtained, a least squares regression was performed to fit how large 
(bright) each of these peaks need to be to explain the observed spectrum at each wavelength. To 
account for L-anap shifts, the least squares fit is calculated at one particular wavelength of L-anap, 
and the residual is recorded. The code iterates until residuals are minimized, resulting in the best 
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fit overall, not just in terms of how large the peaks need to be, but also what the central wavelength 
of the L-anap peak needs to be. On the short-wavelength side of the L-anap spectra, a shift will 
always look slightly weaker, since as the spectrum blue-shifts, it reaches the edge of the notch 
filter. However, only with extreme blue shifts does this effect become important; for the spectra 
observed in these experiments, it is a small effect. 
Imaging data analysis workflow 
 
Together, the spectral imaging data analysis workflow of K-depolarization data is shown in Figure 
5.2. +L-anap ROIs are chosen using the GFP channel as a reference and spectra are unmixed as 
described above. Each L-anap spectrum is normalized to the area of the ROI, then the sum of 







Figure 5.2: Modified linear unmixing workflow. L-anap and GFP spectra were fitted and unmixed 
in MATLAB using model spectra and least squares regression to find best-fits for shifted-L-anap 
spectra. (1) Images are loaded into the linear unmixing program as TIFF stacks. +L-anap ROIs 
were chosen using the +GFP maximum emission image as a reference. At least 12 cells were 
chosen for each condition, spread over four images taken of different locations within the same 
well. (2) Spectra are unmixed and (3) each spectrum is normalized to the area of the ROI, then (4) 
to the sum of intensities under the peak. (5) Spectra are averaged. Error bars are ±SEM. 
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5.9 Plasmids and primers 
 
L-anapRS-LeutRNACUA, pcDNA4-EGFP(Y40TAG) “pSWAN-GFP37TAG”, and pCMV-
MmPylRS-PylT were gifts from Peter G. Schultz [188], [261]. Template plasmid pH2B-EGFP was 
available in the Cornish Lab. Template plasmid pcDNA3-SCN5A hh1c was available in the Kass 
Lab. pH2B-mCherry was a gift from Robert Benezra (Addgene plasmid # 20972). pEGFR-EGFP 
was a gift from Alexander Sorkin (Addgene plasmid # 32751).  
 
 
Table 1: Plasmids 
Name Plasmid Method Primers 
 pcDNA3-SCN5A hH1c   
 
pcDNA3-Hygro-CMV-MmPylRS-U6-
MmPylT "pCMV-MmPylRS-PylT"   
 
pcDNA3-8xH1-EcLeuT-AnapRS "L-
anapRS-LeutRNACUA"   
 
pcDNA4-Myc-6xHis-EGFP(Y40TAG) 
"pSWAN-GFP37TAG"   
 pEGFR-EGFP   
 pH2B-EGFP   
 pH2B-mCherry   




MmPylT    
pMAS11 pcDNA4-Myc-6xHis-wtEGFP site-directed mutagenesis of pSWAN-GFP37TAG oMS65/66 
pMAS12 pcDNA3-SCN5A-EGFP  
Gibson Assembly of two inserts comprising SCN5A onto SalI-
HF_BamHI-HF digested pH2B-EGFP oMS101/102 
pMAS13 pcDNA3-SCN5A(Q1475TAG) site-directed mutagenesis of pcdna3-SCN5A oMS117/118  
pMAS14 pcDNA3-SCN5A(E1489TAG) site-directed mutagenesis of pcdna3-SCN5A oMS145/146 
pMAS15 pcDNA3-SCN5A(E1488TAG) site-directed mutagenesis of pcdna3-SCN5A oMS143/144 
pMAS16 pcDNA3-SCN5A(F1485TAG) site-directed mutagenesis of pcdna3-SCN5A  oMS137/138  
pMAS17 pcDNA3-SCN5A(M1486TAG) site-directed mutagenesis of pcdna3-SCN5A oMS139/140 
pMAS18 pcDNA3-SCN5A(N1473TAG)-EGFP 
Gibson Assembly of two inserts comprising SCN5A w/TAG 







pMAS19 pcDNA3-SCN5A(F1472TAG)-EGFP  site-directed mutagenesis of pMAS12 oMS111/112 
pMAS20 pcDNA3-SCN5A(Q1475TAG)-EGFP site-directed mutagenesis of pMAS12  oMS117/118  
pMAS21 pcDNA3-SCN5A(K1478TAG)-EGFP site-directed mutagenesis of pMAS12 oMS123/124 
pMAS22 pcDNA3-SCN5A(D1483TAG)-EGFP site-directed mutagenesis of pMAS12  oMS133/134 
pMAS23 pcDNA3-SCN5A(F1485TAG)-EGFP site-directed mutagenesis of pMAS12 oMS137/138  
pMAS29 pcDNA3-SCN5A(I1484TAG)-EGFP site-directed mutagenesis of pMAS12 oMS135/136 
pMAS30 pcDNA3-SCN5A-EGFP(Y40TAG) site-directed mutagenesis of pMAS12 oMS211/212 
pMAS34 pH2B(V129TAG)-mCherry site-directed mutagenesis of pH2B-mCherry oMS246/247 
pMAS49 pcDNA3-SCN5A-mCherry 
Gibson Assembly of oMS306/104 4.5kb, oMS308/103 1.6kb SCN5A 








Gibson Assembly of oMS306/229 4.5kb, oMS308/228 1.6kb SCN5A 









Gibson Assembly of oMS316/317 SCN5A(Q1475TAG) 5.7kb insert 




Gibson Assembly of oMS316/317 wild-type SCN5A 5.7kb insert, 






Gibson Assembly of oMS316/144 SCN5A(E1488TAG) 4.5kb insert, 










Table 2: Primers 
Primer 
Name Primer Sequence 
oMS65 
GGCGAGGGCGATGCCACCTACGGC AAG CTG ACC CTG AAG TTC ATC 
T 
oMS66 






GCT CCT CGC CCT TGC TCA CCA TGG TGG CGA CCG 
GTGGATCCACGATGGACTCACGGTCC 
oMS103 AAGTACTACAATGCCATGAAGAAGCTGGGCTCCAAGAAGC 
oMS104 GCT TCT TGG AGC CCA GCT TCT TCA TGG CAT TGT AGT ACT T 
oMS111 TGGTGTCATCATTGATAACTAGAACCAACAGAAGAAAAAGTT 
oMS112 AAC TTT TTC TTC TGT TGG TTC TAG TTA TCA ATG ATG ACA CCA 
oMS117 TCATTGATAACTTCAACCAATAGAAGAAAAAGTTAGGGGGC 
oMS118 GCC CCC TAA CTT TTT CTT CTA TTG GTT GAA GTT ATC AAT GA 
oMS123 ACTTCAACCAACAGAAGAAATAGTTAGGGGGCCAGGACATC 
oMS124 GAT GTC CTG GCC CCC TAA CTA TTT CTT CTG TTG GTT GAA GT 
oMS133 AGAAAAAGTTAGGGGGCCAGTAGATCTTCATGACAGAGGAGCA 
oMS134 TGC TCC TCT GTC ATG AAG ATC TAC TGG CCC CCT AAC TTT TTC T 
oMS135 AAAAGTTAGGGGGCCAGGACTAGTTCATGACAGAGGAGCAGAA 
oMS136 TTC TGC TCC TCT GTC ATG AAC TAG TCC TGG CCC CCT AAC TTT T  
oMS137 GTTAGGGGGCCAGGACATCTAGATGACAGAGGAGCAGAAGAA 
oMS138 TTC TTC TGC TCC TCT GTC ATC TAG ATG TCC TGG CCC CCT AAC 
oMS139 TAGGGGGCCAGGACATCTTCTAGACAGAGGAGCAGAAGAAGT 
oMS140 ACT TCT TCT GCT CCT CTG TCT AGA AGA TGT CCT GGC CCC CTA 
oMS143 GCCAGGACATCTTCATGACATAGGAGCAGAAGAAGTACTAC 
oMS144 GTA GTA CTT CTT CTG CTC CTA TGT CAT GAA GAT GTC CTG GC 
oMS145 AGGACATCTTCATGACAGAGTAGCAGAAGAAGTACTACAAT 
oMS146 ATT GTA GTA CTT CTT CTG CTA CTC TGT CAT GAA GAT GTC CT 
oMS211 GGCGAGGGCGATGCCACCTAGGGCAAGCTGACCCTGAAGTTC 
oMS212 GAA CTT CAG GGT CAG CTT GCC CTA GGT GGC ATC GCC CTC GCC 
oMS228 TCATTGACAACTTCAACCAATAGAAGAAAAAGTTAGGGGGC 
oMS229 GCC CCC TAA CTT TTT CTT CTA TTG GTT GAA GTT GTC AAT GA 
oMS246 CCACCGTAGGCCACCATGGTGAGCAAGGG 




oMS308 CAC CAT GGT GGC GAC CGG TGG ATC CAC GAT GGA CTC ACG GTC C 
oMS309 GATCCACCGGTCGCCACCATG 
oMS310 GGT GGC GGT ACC AAG CTT GGG 
oMS316 GTGCCCAGAAGCAGGATGAGAAGATGGCAAACTTCCTATTACCTCGG 
oMS317 
CTC TAG ATG CAT GCT CGA GCG GCC GCT CAT GGG TTG GCT GCC 
ATG AAC T 
oMS318 GCGGCCGCTCGAGCATGCATCTAGAGG 
oMS319 GCC ATC TTC TCA TCC TGC TTC TGG GCA CAG GCT 
AVA474 
CTT CAG TCC GGT TTT CTA TGC ATC ATA GTT AGA TAA GAC TGC 
TAA G 
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